,title,publish_time,journal,url,abstract,doi,cord_uid,words
4706,Diagnostic accuracy and utility of three dengue diagnostic tests for the diagnosis of acute dengue infection in Malaysia,2020-03-12,BMC Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069157/,"BACKGROUND: Dengue is an emerging infectious disease that infects up to 390 million people yearly. The growing demand of dengue diagnostics especially in low-resource settings gave rise to many rapid diagnostic tests (RDT). This study evaluated the accuracy and utility of ViroTrack Dengue Acute - a new biosensors-based dengue NS1 RDT, SD Bioline Dengue Duo NS1/IgM/IgG combo - a commercially available RDT, and SD Dengue NS1 Ag enzyme-linked immunosorbent assay (ELISA), for the diagnosis of acute dengue infection. METHODS: This prospective cross-sectional study consecutively recruited 494 patients with suspected dengue from a health clinic in Malaysia. Both RDTs were performed onsite. The evaluated ELISA and reference tests were performed in a virology laboratory. The reference tests comprised of a reverse transcription-polymerase chain reaction and three ELISAs for the detection of dengue NS1 antigen, IgM and IgG antibodies, respectively. The diagnostic performance of evaluated tests was computed using STATA version 12. RESULTS: The sensitivity and specificity of ViroTrack were 62.3% (95%CI 55.6–68.7) and 95.0% (95%CI 91.7–97.3), versus 66.5% (95%CI 60.0–72.6) and 95.4% (95%CI 92.1–97.6) for SD NS1 ELISA, and 52.4% (95%CI 45.7–59.1) and 97.7% (95%CI 95.1–99.2) for NS1 component of SD Bioline, respectively. The combination of the latter with its IgM and IgG components were able to increase test sensitivity to 82.4% (95%CI 76.8–87.1) with corresponding decrease in specificity to 87.4% (95%CI 82.8–91.2). Although a positive test on any of the NS1 assays would increase the probability of dengue to above 90% in a patient, a negative result would only reduce this probability to 23.0–29.3%. In contrast, this probability of false negative diagnosis would be further reduced to 14.7% (95%CI 11.4–18.6) if SD Bioline NS1/IgM/IgG combo was negative. CONCLUSIONS: The performance of ViroTrack Dengue Acute was comparable to SD Dengue NS1 Ag ELISA. Addition of serology components to SD Bioline Dengue Duo significantly improved its sensitivity and reduced its false negative rate such that it missed the fewest dengue patients, making it a better point-of-care diagnostic tool. New RDT like ViroTrack Dengue Acute may be a potential alternative to existing RDT if its combination with serology components is proven better in future studies.",10.1186/s12879-020-4911-5,r50atew9,"['BACKGROUND', 'Dengue', 'is', 'an', 'emerging', 'infectious', 'disease', 'that', 'infects', 'up', 'to', '390', 'million', 'people', 'yearly', 'The', 'growing', 'demand', 'of', 'dengue', 'diagnostics', 'especially', 'in', 'low', 'resource', 'settings', 'gave', 'rise', 'to', 'many', 'rapid', 'diagnostic', 'tests', 'RDT', 'This', 'study', 'evaluated', 'the', 'accuracy', 'and', 'utility', 'of', 'ViroTrack', 'Dengue', 'Acute', 'a', 'new', 'biosensors', 'based', 'dengue', 'NS1', 'RDT', 'SD', 'Bioline', 'Dengue', 'Duo', 'NS1', 'IgM', 'IgG', 'combo', 'a', 'commercially', 'available', 'RDT', 'and', 'SD', 'Dengue', 'NS1', 'Ag', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'for', 'the', 'diagnosis', 'of', 'acute', 'dengue', 'infection', 'METHODS', 'This', 'prospective', 'cross', 'sectional', 'study', 'consecutively', 'recruited', '494', 'patients', 'with', 'suspected', 'dengue', 'from', 'a', 'health', 'clinic', 'in', 'Malaysia', 'Both', 'RDTs', 'were', 'performed', 'onsite', 'The', 'evaluated', 'ELISA', 'and', 'reference', 'tests', 'were', 'performed', 'in', 'a', 'virology', 'laboratory', 'The', 'reference', 'tests', 'comprised', 'of', 'a', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'and', 'three', 'ELISAs', 'for', 'the', 'detection', 'of', 'dengue', 'NS1', 'antigen', 'IgM', 'and', 'IgG', 'antibodies', 'respectively', 'The', 'diagnostic', 'performance', 'of', 'evaluated', 'tests', 'was', 'computed', 'using', 'STATA', 'version', '12', 'RESULTS', 'The', 'sensitivity', 'and', 'specificity', 'of', 'ViroTrack', 'were', '62', '3', '95', 'CI', '55', '6', '68', '7', 'and', '95', '0', '95', 'CI', '91', '7', '97', '3', 'versus', '66', '5', '95', 'CI', '60', '0', '72', '6', 'and', '95', '4', '95', 'CI', '92', '1', '97', '6', 'for', 'SD', 'NS1', 'ELISA', 'and', '52', '4', '95', 'CI', '45', '7', '59', '1', 'and', '97', '7', '95', 'CI', '95', '1', '99', '2', 'for', 'NS1', 'component', 'of', 'SD', 'Bioline', 'respectively', 'The', 'combination', 'of', 'the', 'latter', 'with', 'its', 'IgM', 'and', 'IgG', 'components', 'were', 'able', 'to', 'increase', 'test', 'sensitivity', 'to', '82', '4', '95', 'CI', '76', '8', '87', '1', 'with', 'corresponding', 'decrease', 'in', 'specificity', 'to', '87', '4', '95', 'CI', '82', '8', '91', '2', 'Although', 'a', 'positive', 'test', 'on', 'any', 'of', 'the', 'NS1', 'assays', 'would', 'increase', 'the', 'probability', 'of', 'dengue', 'to', 'above', '90', 'in', 'a', 'patient', 'a', 'negative', 'result', 'would', 'only', 'reduce', 'this', 'probability', 'to', '23', '0', '29', '3', 'In', 'contrast', 'this', 'probability', 'of', 'false', 'negative', 'diagnosis', 'would', 'be', 'further', 'reduced', 'to', '14', '7', '95', 'CI', '11', '4', '18', '6', 'if', 'SD', 'Bioline', 'NS1', 'IgM', 'IgG', 'combo', 'was', 'negative', 'CONCLUSIONS', 'The', 'performance', 'of', 'ViroTrack', 'Dengue', 'Acute', 'was', 'comparable', 'to', 'SD', 'Dengue', 'NS1', 'Ag', 'ELISA', 'Addition', 'of', 'serology', 'components', 'to', 'SD', 'Bioline', 'Dengue', 'Duo', 'significantly', 'improved', 'its', 'sensitivity', 'and', 'reduced', 'its', 'false', 'negative', 'rate', 'such', 'that', 'it', 'missed', 'the', 'fewest', 'dengue', 'patients', 'making', 'it', 'a', 'better', 'point', 'of', 'care', 'diagnostic', 'tool', 'New', 'RDT', 'like', 'ViroTrack', 'Dengue', 'Acute', 'may', 'be', 'a', 'potential', 'alternative', 'to', 'existing', 'RDT', 'if', 'its', 'combination', 'with', 'serology', 'components', 'is', 'proven', 'better', 'in', 'future', 'studies', '']"
5730,Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology,2020-03-24,Sci Rep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093460/,"The detection of pathogen-specific antibodies remains a cornerstone of clinical diagnostics. Yet, many test exhibit undesirable performance or are completely lacking. Given this, we developed serum epitope repertoire analysis (SERA), a method to rapidly discover conserved, pathogen-specific antigens and their epitopes, and applied it to develop an assay for Chagas disease caused by the protozoan parasite Trypanosoma cruzi. Antibody binding peptide motifs were identified from 28 Chagas repertoires using a bacterial display random 12-mer peptide library and next-generation sequencing (NGS). Thirty-three motifs were selected and mapped to candidate Chagas antigens. In a blinded validation set (n = 72), 30/30 Chagas were positive, 30/30 non-Chagas were negative, and 1/12 Leishmania sp. was positive. After unblinding, a Leishmania cross-reactive epitope was identified and removed from the panel. The Chagas assay exhibited 100% sensitivity (30/30) and specificity (90/90) in a second blinded validation set including individuals with other parasitic infections. Amongst additional epitope repertoires with unknown Chagas serostatus, assay specificity was 99.8% (998/1000). Thus, the Chagas assay achieved a combined sensitivity and specificity equivalent or superior to diagnostic algorithms that rely on three separate tests to achieve high specificity. NGS-based serology via SERA provides an effective approach to discover antigenic epitopes and develop high performance multiplex serological assays.",10.1038/s41598-020-62256-9,equnyib7,"['The', 'detection', 'of', 'pathogen', 'specific', 'antibodies', 'remains', 'a', 'cornerstone', 'of', 'clinical', 'diagnostics', 'Yet', 'many', 'test', 'exhibit', 'undesirable', 'performance', 'or', 'are', 'completely', 'lacking', 'Given', 'this', 'we', 'developed', 'serum', 'epitope', 'repertoire', 'analysis', 'SERA', 'a', 'method', 'to', 'rapidly', 'discover', 'conserved', 'pathogen', 'specific', 'antigens', 'and', 'their', 'epitopes', 'and', 'applied', 'it', 'to', 'develop', 'an', 'assay', 'for', 'Chagas', 'disease', 'caused', 'by', 'the', 'protozoan', 'parasite', 'Trypanosoma', 'cruzi', 'Antibody', 'binding', 'peptide', 'motifs', 'were', 'identified', 'from', '28', 'Chagas', 'repertoires', 'using', 'a', 'bacterial', 'display', 'random', '12', 'mer', 'peptide', 'library', 'and', 'next', 'generation', 'sequencing', 'NGS', 'Thirty', 'three', 'motifs', 'were', 'selected', 'and', 'mapped', 'to', 'candidate', 'Chagas', 'antigens', 'In', 'a', 'blinded', 'validation', 'set', 'n', '72', '30', '30', 'Chagas', 'were', 'positive', '30', '30', 'non', 'Chagas', 'were', 'negative', 'and', '1', '12', 'Leishmania', 'sp', 'was', 'positive', 'After', 'unblinding', 'a', 'Leishmania', 'cross', 'reactive', 'epitope', 'was', 'identified', 'and', 'removed', 'from', 'the', 'panel', 'The', 'Chagas', 'assay', 'exhibited', '100', 'sensitivity', '30', '30', 'and', 'specificity', '90', '90', 'in', 'a', 'second', 'blinded', 'validation', 'set', 'including', 'individuals', 'with', 'other', 'parasitic', 'infections', 'Amongst', 'additional', 'epitope', 'repertoires', 'with', 'unknown', 'Chagas', 'serostatus', 'assay', 'specificity', 'was', '99', '8', '998', '1000', 'Thus', 'the', 'Chagas', 'assay', 'achieved', 'a', 'combined', 'sensitivity', 'and', 'specificity', 'equivalent', 'or', 'superior', 'to', 'diagnostic', 'algorithms', 'that', 'rely', 'on', 'three', 'separate', 'tests', 'to', 'achieve', 'high', 'specificity', 'NGS', 'based', 'serology', 'via', 'SERA', 'provides', 'an', 'effective', 'approach', 'to', 'discover', 'antigenic', 'epitopes', 'and', 'develop', 'high', 'performance', 'multiplex', 'serological', 'assays', '']"
14541,Diagnosis of Viral Infections,2017-05-05,"Viral Infections in Children, Volume I",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120824/,"Accurate diagnosis of viral infections enhances the ability of the clinician to make decisions on appropriate treatment of patients, evaluate disease progression and prevent misuse of antibiotics. Knowledge of the pathogen involved also allow implementation of infection control and monitoring of success of antiviral treatments that may affect the prognosis of patients. Epidemiological data collected through accurate diagnostics play an important role in public health through identification and control of outbreaks, implementation of appropriate diagnostic tests, vaccination programs and treatment but also to recognize common and emerging pathogens in a community. It is key that the clinician have an understanding of appropriate specimens to send to the laboratory and the value of specific nucleic acid and serological testing for different viral pathogens. Molecular techniques have revolutionized viral diagnoses over the past decade and enhanced both the sensitivity and specificity of tests and the speed by which a diagnosis can be made and new tests be developed. The continued use of serology for viruses with a short viremia, or for chronic infections should however complement these tests. This chapter aims to provide an overview of the available tests, the principles of testing and appropriate tests to select for different viruses and syndromes. Also provided is a glimpse of new developments in diagnostics that may further enhance the capacity to make a conclusive diagnosis in the near future.",10.1007/978-3-319-54033-7_6,z31g3mr5,"['Accurate', 'diagnosis', 'of', 'viral', 'infections', 'enhances', 'the', 'ability', 'of', 'the', 'clinician', 'to', 'make', 'decisions', 'on', 'appropriate', 'treatment', 'of', 'patients', 'evaluate', 'disease', 'progression', 'and', 'prevent', 'misuse', 'of', 'antibiotics', 'Knowledge', 'of', 'the', 'pathogen', 'involved', 'also', 'allow', 'implementation', 'of', 'infection', 'control', 'and', 'monitoring', 'of', 'success', 'of', 'antiviral', 'treatments', 'that', 'may', 'affect', 'the', 'prognosis', 'of', 'patients', 'Epidemiological', 'data', 'collected', 'through', 'accurate', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'public', 'health', 'through', 'identification', 'and', 'control', 'of', 'outbreaks', 'implementation', 'of', 'appropriate', 'diagnostic', 'tests', 'vaccination', 'programs', 'and', 'treatment', 'but', 'also', 'to', 'recognize', 'common', 'and', 'emerging', 'pathogens', 'in', 'a', 'community', 'It', 'is', 'key', 'that', 'the', 'clinician', 'have', 'an', 'understanding', 'of', 'appropriate', 'specimens', 'to', 'send', 'to', 'the', 'laboratory', 'and', 'the', 'value', 'of', 'specific', 'nucleic', 'acid', 'and', 'serological', 'testing', 'for', 'different', 'viral', 'pathogens', 'Molecular', 'techniques', 'have', 'revolutionized', 'viral', 'diagnoses', 'over', 'the', 'past', 'decade', 'and', 'enhanced', 'both', 'the', 'sensitivity', 'and', 'specificity', 'of', 'tests', 'and', 'the', 'speed', 'by', 'which', 'a', 'diagnosis', 'can', 'be', 'made', 'and', 'new', 'tests', 'be', 'developed', 'The', 'continued', 'use', 'of', 'serology', 'for', 'viruses', 'with', 'a', 'short', 'viremia', 'or', 'for', 'chronic', 'infections', 'should', 'however', 'complement', 'these', 'tests', 'This', 'chapter', 'aims', 'to', 'provide', 'an', 'overview', 'of', 'the', 'available', 'tests', 'the', 'principles', 'of', 'testing', 'and', 'appropriate', 'tests', 'to', 'select', 'for', 'different', 'viruses', 'and', 'syndromes', 'Also', 'provided', 'is', 'a', 'glimpse', 'of', 'new', 'developments', 'in', 'diagnostics', 'that', 'may', 'further', 'enhance', 'the', 'capacity', 'to', 'make', 'a', 'conclusive', 'diagnosis', 'in', 'the', 'near', 'future', '']"
27521,A Review of the Diagnosis and Management of Hepatitis E,2020-07-17,Curr Treat Options Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366488/,"PURPOSE OF REVIEW: We aim to provide the readers an up-to-date knowledge of the structure, epidemiology, and transmission followed by a detailed discussion on testing, diagnostics and management of hepatitis E virus infection. We have also included a comprehensive review of hepatitis E in pregnancy. RECENT FINDINGS: European Association for the Study of the Liver established clinical practice guidelines for testing and treatment of suspected hepatitis E virus infections in 2018. Evidence suggests chronic hepatitis E may follow a course similar to hepatitis B/C with progression to cirrhosis and possibly hepatocellular carcinoma in immunocompromised patients. SUMMARY: Hepatitis E virus is the most common cause of acute viral hepatitis worldwide. A combination of serology and nucleic acid amplification testing is the recommended strategy for suspected patients. Ribavirin therapy for a period of 3 months is the drug of choice for severe acute hepatitis, acute-on chronic liver failure, and chronic infections from hepatitis E virus in immunocompromised patients who are unresponsive to decreased immunosuppression. PEGylated interferon α can be used for ribavirin-resistant liver transplant patients with chronic hepatitis E. Further research in therapeutic options is essential considering the stormy course of hepatitis E infection during pregnancy and teratogenicity of all available options.",10.1007/s40506-020-00235-4,06ur0oip,"['PURPOSE', 'OF', 'REVIEW', 'We', 'aim', 'to', 'provide', 'the', 'readers', 'an', 'up', 'to', 'date', 'knowledge', 'of', 'the', 'structure', 'epidemiology', 'and', 'transmission', 'followed', 'by', 'a', 'detailed', 'discussion', 'on', 'testing', 'diagnostics', 'and', 'management', 'of', 'hepatitis', 'E', 'virus', 'infection', 'We', 'have', 'also', 'included', 'a', 'comprehensive', 'review', 'of', 'hepatitis', 'E', 'in', 'pregnancy', 'RECENT', 'FINDINGS', 'European', 'Association', 'for', 'the', 'Study', 'of', 'the', 'Liver', 'established', 'clinical', 'practice', 'guidelines', 'for', 'testing', 'and', 'treatment', 'of', 'suspected', 'hepatitis', 'E', 'virus', 'infections', 'in', '2018', 'Evidence', 'suggests', 'chronic', 'hepatitis', 'E', 'may', 'follow', 'a', 'course', 'similar', 'to', 'hepatitis', 'B', 'C', 'with', 'progression', 'to', 'cirrhosis', 'and', 'possibly', 'hepatocellular', 'carcinoma', 'in', 'immunocompromised', 'patients', 'SUMMARY', 'Hepatitis', 'E', 'virus', 'is', 'the', 'most', 'common', 'cause', 'of', 'acute', 'viral', 'hepatitis', 'worldwide', 'A', 'combination', 'of', 'serology', 'and', 'nucleic', 'acid', 'amplification', 'testing', 'is', 'the', 'recommended', 'strategy', 'for', 'suspected', 'patients', 'Ribavirin', 'therapy', 'for', 'a', 'period', 'of', '3', 'months', 'is', 'the', 'drug', 'of', 'choice', 'for', 'severe', 'acute', 'hepatitis', 'acute', 'on', 'chronic', 'liver', 'failure', 'and', 'chronic', 'infections', 'from', 'hepatitis', 'E', 'virus', 'in', 'immunocompromised', 'patients', 'who', 'are', 'unresponsive', 'to', 'decreased', 'immunosuppression', 'PEGylated', 'interferon', 'α', 'can', 'be', 'used', 'for', 'ribavirin', 'resistant', 'liver', 'transplant', 'patients', 'with', 'chronic', 'hepatitis', 'E', 'Further', 'research', 'in', 'therapeutic', 'options', 'is', 'essential', 'considering', 'the', 'stormy', 'course', 'of', 'hepatitis', 'E', 'infection', 'during', 'pregnancy', 'and', 'teratogenicity', 'of', 'all', 'available', 'options', '']"
28766,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois.",2020-07-09,Current opinion in rheumatology,https://doi.org/10.1097/bor.0000000000000728; https://www.ncbi.nlm.nih.gov/pubmed/32657802/,"BACKGROUND Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",10.1097/bor.0000000000000728,ugx8unte,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
43827,Achieving molecular diagnostics for Lyme disease.,2013,Expert review of molecular diagnostics,https://doi.org/10.1586/14737159.2013.850418; https://www.ncbi.nlm.nih.gov/pubmed/24151851/,"Early Lyme disease is often difficult to diagnose. Left untreated, symptoms can last for many years leading to chronic health problems. Serological tests for the presence of antibodies that react to Borrelia burgdorferi antigens are generally used to support a clinical diagnosis. Due to the biologically delayed antibody response, serology is negative in many patients in the initial 3 weeks after infection and a single test cannot be used to demonstrate active disease, although certain specialized tests provide strong correlation. Because of these limitations there exists a need for better diagnostics for Lyme disease that can detect Borrelia genomic material at the onset of symptoms.",10.1586/14737159.2013.850418,u31i00w6,"['Early', 'Lyme', 'disease', 'is', 'often', 'difficult', 'to', 'diagnose', 'Left', 'untreated', 'symptoms', 'can', 'last', 'for', 'many', 'years', 'leading', 'to', 'chronic', 'health', 'problems', 'Serological', 'tests', 'for', 'the', 'presence', 'of', 'antibodies', 'that', 'react', 'to', 'Borrelia', 'burgdorferi', 'antigens', 'are', 'generally', 'used', 'to', 'support', 'a', 'clinical', 'diagnosis', 'Due', 'to', 'the', 'biologically', 'delayed', 'antibody', 'response', 'serology', 'is', 'negative', 'in', 'many', 'patients', 'in', 'the', 'initial', '3', 'weeks', 'after', 'infection', 'and', 'a', 'single', 'test', 'cannot', 'be', 'used', 'to', 'demonstrate', 'active', 'disease', 'although', 'certain', 'specialized', 'tests', 'provide', 'strong', 'correlation', 'Because', 'of', 'these', 'limitations', 'there', 'exists', 'a', 'need', 'for', 'better', 'diagnostics', 'for', 'Lyme', 'disease', 'that', 'can', 'detect', 'Borrelia', 'genomic', 'material', 'at', 'the', 'onset', 'of', 'symptoms', '']"
44349,Markers of Borna disease virus infection in cats with staggering disease.,2012,Journal of feline medicine and surgery,https://doi.org/10.1177/1098612x12446638; https://www.ncbi.nlm.nih.gov/pubmed/22553310/,"Borna disease virus (BDV) is a RNA-virus causing neurological disorders in a wide range of mammals. In cats, BDV infection may cause staggering disease. Presently, staggering disease is a tentative clinical diagnosis, only confirmed at necropsy. In this study, cats with staggering disease were investigated to study markers of BDV infection aiming for improvement of current diagnostics. Nineteen cats fulfilled the inclusion criteria based on neurological signs and pathological findings. In 17/19 cats, BDV infection markers (BDV-specific antibodies and/or BDV-RNA) were found, and antibodies in serum (13/16, 81%) were the most common marker. BDV-RNA was found in 11/19 cats (58%). In a reference population without neurological signs, 4/25 cats were seropositive (16%). The clinical history and neurological signs in combination with presence of BDV infection markers, where serology and rRT-PCR on blood can be helpful tools, improve the diagnostic accuracy in the living cat.",10.1177/1098612x12446638,vw6t0alg,"['Borna', 'disease', 'virus', 'BDV', 'is', 'a', 'RNA', 'virus', 'causing', 'neurological', 'disorders', 'in', 'a', 'wide', 'range', 'of', 'mammals', 'In', 'cats', 'BDV', 'infection', 'may', 'cause', 'staggering', 'disease', 'Presently', 'staggering', 'disease', 'is', 'a', 'tentative', 'clinical', 'diagnosis', 'only', 'confirmed', 'at', 'necropsy', 'In', 'this', 'study', 'cats', 'with', 'staggering', 'disease', 'were', 'investigated', 'to', 'study', 'markers', 'of', 'BDV', 'infection', 'aiming', 'for', 'improvement', 'of', 'current', 'diagnostics', 'Nineteen', 'cats', 'fulfilled', 'the', 'inclusion', 'criteria', 'based', 'on', 'neurological', 'signs', 'and', 'pathological', 'findings', 'In', '17', '19', 'cats', 'BDV', 'infection', 'markers', 'BDV', 'specific', 'antibodies', 'and', 'or', 'BDV', 'RNA', 'were', 'found', 'and', 'antibodies', 'in', 'serum', '13', '16', '81', 'were', 'the', 'most', 'common', 'marker', 'BDV', 'RNA', 'was', 'found', 'in', '11', '19', 'cats', '58', 'In', 'a', 'reference', 'population', 'without', 'neurological', 'signs', '4', '25', 'cats', 'were', 'seropositive', '16', 'The', 'clinical', 'history', 'and', 'neurological', 'signs', 'in', 'combination', 'with', 'presence', 'of', 'BDV', 'infection', 'markers', 'where', 'serology', 'and', 'rRT', 'PCR', 'on', 'blood', 'can', 'be', 'helpful', 'tools', 'improve', 'the', 'diagnostic', 'accuracy', 'in', 'the', 'living', 'cat', '']"
47018,Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria.,2013,Thorax,https://doi.org/10.1136/thoraxjnl-2013-203551; https://www.ncbi.nlm.nih.gov/pubmed/23783373/,"BACKGROUND Adult community-acquired pneumonia (CAP) is a relevant worldwide cause of morbidity and mortality, however the aetiology often remains uncertain and the therapy is empirical. We applied conventional and molecular diagnostics to identify viruses and atypical bacteria associated with CAP in Chile. METHODS We used sputum and blood cultures, IgG/IgM serology and molecular diagnostic techniques (PCR, reverse transcriptase PCR) for detection of classical and atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumoniae) and respiratory viruses (adenovirus, respiratory syncytial virus (RSV), human metapneumovirus, influenza virus, parainfluenzavirus, rhinovirus, coronavirus) in adults >18 years old presenting with CAP in Santiago from February 2005 to September 2007. Severity was qualified at admission by Fine's pneumonia severity index. RESULTS Overall detection in 356 enrolled adults were 92 (26%) cases of a single bacterial pathogen, 80 (22%) cases of a single viral pathogen, 60 (17%) cases with mixed bacterial and viral infection and 124 (35%) cases with no identified pathogen. Streptococcus pneumoniae and RSV were the most common bacterial and viral pathogens identified. Infectious agent detection by PCR provided greater sensitivity than conventional techniques. To our surprise, no relationship was observed between clinical severity and sole or coinfections. CONCLUSIONS The use of molecular diagnostics expanded the detection of viruses and atypical bacteria in adults with CAP, as unique or coinfections. Clinical severity and outcome were independent of the aetiological agents detected.",10.1136/thoraxjnl-2013-203551,vpf8bzs3,"['BACKGROUND', 'Adult', 'community', 'acquired', 'pneumonia', 'CAP', 'is', 'a', 'relevant', 'worldwide', 'cause', 'of', 'morbidity', 'and', 'mortality', 'however', 'the', 'aetiology', 'often', 'remains', 'uncertain', 'and', 'the', 'therapy', 'is', 'empirical', 'We', 'applied', 'conventional', 'and', 'molecular', 'diagnostics', 'to', 'identify', 'viruses', 'and', 'atypical', 'bacteria', 'associated', 'with', 'CAP', 'in', 'Chile', 'METHODS', 'We', 'used', 'sputum', 'and', 'blood', 'cultures', 'IgG', 'IgM', 'serology', 'and', 'molecular', 'diagnostic', 'techniques', 'PCR', 'reverse', 'transcriptase', 'PCR', 'for', 'detection', 'of', 'classical', 'and', 'atypical', 'bacteria', 'Mycoplasma', 'pneumoniae', 'Chlamydia', 'pneumoniae', 'Legionella', 'pneumoniae', 'and', 'respiratory', 'viruses', 'adenovirus', 'respiratory', 'syncytial', 'virus', 'RSV', 'human', 'metapneumovirus', 'influenza', 'virus', 'parainfluenzavirus', 'rhinovirus', 'coronavirus', 'in', 'adults', '18', 'years', 'old', 'presenting', 'with', 'CAP', 'in', 'Santiago', 'from', 'February', '2005', 'to', 'September', '2007', 'Severity', 'was', 'qualified', 'at', 'admission', 'by', 'Fine', 's', 'pneumonia', 'severity', 'index', 'RESULTS', 'Overall', 'detection', 'in', '356', 'enrolled', 'adults', 'were', '92', '26', 'cases', 'of', 'a', 'single', 'bacterial', 'pathogen', '80', '22', 'cases', 'of', 'a', 'single', 'viral', 'pathogen', '60', '17', 'cases', 'with', 'mixed', 'bacterial', 'and', 'viral', 'infection', 'and', '124', '35', 'cases', 'with', 'no', 'identified', 'pathogen', 'Streptococcus', 'pneumoniae', 'and', 'RSV', 'were', 'the', 'most', 'common', 'bacterial', 'and', 'viral', 'pathogens', 'identified', 'Infectious', 'agent', 'detection', 'by', 'PCR', 'provided', 'greater', 'sensitivity', 'than', 'conventional', 'techniques', 'To', 'our', 'surprise', 'no', 'relationship', 'was', 'observed', 'between', 'clinical', 'severity', 'and', 'sole', 'or', 'coinfections', 'CONCLUSIONS', 'The', 'use', 'of', 'molecular', 'diagnostics', 'expanded', 'the', 'detection', 'of', 'viruses', 'and', 'atypical', 'bacteria', 'in', 'adults', 'with', 'CAP', 'as', 'unique', 'or', 'coinfections', 'Clinical', 'severity', 'and', 'outcome', 'were', 'independent', 'of', 'the', 'aetiological', 'agents', 'detected', '']"
49504,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management.,2020-04-29,IEEE reviews in biomedical engineering,https://doi.org/10.1109/rbme.2020.2991444; https://www.ncbi.nlm.nih.gov/pubmed/32356761/,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",10.1109/rbme.2020.2991444,6wlbl0wg,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
58249,"The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia.",2014,Journal of medical microbiology,https://doi.org/10.1099/jmm.0.067108-0; https://www.ncbi.nlm.nih.gov/pubmed/24344207/,"Current diagnostics for community-acquired pneumonia (CAP) include testing for a wide range of pathogens, which is costly and not always informative. We compared clinical and laboratory parameters of patients with CAP caused by different groups of pathogens to evaluate the potential for targeted diagnostics and directed treatment. In a prospective study, conducted between April 2008 and April 2009, adult patients with CAP were tested for the presence of a broad range of possible respiratory pathogens using bacterial cultures, PCR, urinary antigen testing and serology. Of 408 patients with CAP, pathogens were detected in 263 patients (64.5%). Streptococcus pneumoniae and influenza A virus were the most frequently identified bacterial and viral pathogens, respectively. Age had a significant effect on the prediction of aetiology (P = 0.054), with an increase in the relative contribution of viruses with advancing age. Multivariate analyses further showed that the presence of cough increased the likelihood of detecting a viral pathogen [odds ratio (OR) 5.536, 95% confidence interval (CI) 2.130-14.390], the presence of immunodeficiency decreased the likelihood of detecting a bacterial pathogen (OR 0.595, 95 % CI 0.246-1.437) and an increase in pneumonia severity index score increased the likelihood of detecting a pathogen in general. Although several variables were independently associated with the detection of a pathogen group, substantial overlap meant there were no reliable clinical predictors to distinguish aetiologies. Therefore, testing for common respiratory pathogens is still necessary to optimize treatment.",10.1099/jmm.0.067108-0,rq37ljed,"['Current', 'diagnostics', 'for', 'community', 'acquired', 'pneumonia', 'CAP', 'include', 'testing', 'for', 'a', 'wide', 'range', 'of', 'pathogens', 'which', 'is', 'costly', 'and', 'not', 'always', 'informative', 'We', 'compared', 'clinical', 'and', 'laboratory', 'parameters', 'of', 'patients', 'with', 'CAP', 'caused', 'by', 'different', 'groups', 'of', 'pathogens', 'to', 'evaluate', 'the', 'potential', 'for', 'targeted', 'diagnostics', 'and', 'directed', 'treatment', 'In', 'a', 'prospective', 'study', 'conducted', 'between', 'April', '2008', 'and', 'April', '2009', 'adult', 'patients', 'with', 'CAP', 'were', 'tested', 'for', 'the', 'presence', 'of', 'a', 'broad', 'range', 'of', 'possible', 'respiratory', 'pathogens', 'using', 'bacterial', 'cultures', 'PCR', 'urinary', 'antigen', 'testing', 'and', 'serology', 'Of', '408', 'patients', 'with', 'CAP', 'pathogens', 'were', 'detected', 'in', '263', 'patients', '64', '5', 'Streptococcus', 'pneumoniae', 'and', 'influenza', 'A', 'virus', 'were', 'the', 'most', 'frequently', 'identified', 'bacterial', 'and', 'viral', 'pathogens', 'respectively', 'Age', 'had', 'a', 'significant', 'effect', 'on', 'the', 'prediction', 'of', 'aetiology', 'P', '0', '054', 'with', 'an', 'increase', 'in', 'the', 'relative', 'contribution', 'of', 'viruses', 'with', 'advancing', 'age', 'Multivariate', 'analyses', 'further', 'showed', 'that', 'the', 'presence', 'of', 'cough', 'increased', 'the', 'likelihood', 'of', 'detecting', 'a', 'viral', 'pathogen', 'odds', 'ratio', 'OR', '5', '536', '95', 'confidence', 'interval', 'CI', '2', '130', '14', '390', 'the', 'presence', 'of', 'immunodeficiency', 'decreased', 'the', 'likelihood', 'of', 'detecting', 'a', 'bacterial', 'pathogen', 'OR', '0', '595', '95', 'CI', '0', '246', '1', '437', 'and', 'an', 'increase', 'in', 'pneumonia', 'severity', 'index', 'score', 'increased', 'the', 'likelihood', 'of', 'detecting', 'a', 'pathogen', 'in', 'general', 'Although', 'several', 'variables', 'were', 'independently', 'associated', 'with', 'the', 'detection', 'of', 'a', 'pathogen', 'group', 'substantial', 'overlap', 'meant', 'there', 'were', 'no', 'reliable', 'clinical', 'predictors', 'to', 'distinguish', 'aetiologies', 'Therefore', 'testing', 'for', 'common', 'respiratory', 'pathogens', 'is', 'still', 'necessary', 'to', 'optimize', 'treatment', '']"
65800,Diagnostic strategies for healthcare-associated pneumonia.,2009,Seminars in respiratory and critical care medicine,https://doi.org/10.1055/s-0028-1119807; https://www.ncbi.nlm.nih.gov/pubmed/19199185/,"The first point of a good diagnostic strategy for healthcare-associated pneumonia (HCAP) is correct classification of patients with specific criteria, as suggested by the last American Thoracic Society/ Infectious Diseases Society of America (ATS/IDSA) guidelines. However, clinical practice and recent literature have suggested new risk factors for multidrug-resistant infection (MRI): the presence of permanent indwelling devices, prior antibiotic use in the last 3 months, chronic and advanced pulmonary diseases (chronic obstructive pulmonary disease, bronchiectasis, etc.), history of alcoholism, and immunosuppression. The clinical presentation in HCAP patients is often unusual (mild respiratory symptoms and frequent extrapulmonary manifestations) due to different factors: advanced age, neurological disorders, and multiple chronic comorbidities. Moreover, HCAP commonly presents a worse clinical course than community-acquired pneumonia, a prolonged length of stay, and a mortality rate close to hospital-acquired pneumonia. Chest radiography and routine laboratory markers (including C-reactive protein) are always needed for clinical evaluation and severity assessment. The clinical use of new biomarkers of infection and sepsis (procalcitonin, etc.) is currently being investigated. Extensive microbiological testing to overcome the high prevalence of MRI in HCAP, including urinary antigens for Legionella and Streptococcus pneumoniae; blood cultures; Gram staining and low respiratory tract secretions (sputum, tracheobronchial aspirate, fibrobronchial aspirate, protected specimen brush, bronchoalveolar lavage); and cultures for aerobic, anaerobic, mycobacterial, and fungal pathogens are recommended, whereas the indication for serology tests for respiratory viruses and atypical pathogens is low. By contrast, the new polymerase chain reaction-based techniques for the rapid identification (2 to 4 hours) of microbial pathogens in respiratory samples (nasopharyngeal swab, bronchoalveolar lavage) seem to be the most innovative future perspective in the diagnostics of HCAP.",10.1055/s-0028-1119807,oiwue2k5,"['The', 'first', 'point', 'of', 'a', 'good', 'diagnostic', 'strategy', 'for', 'healthcare', 'associated', 'pneumonia', 'HCAP', 'is', 'correct', 'classification', 'of', 'patients', 'with', 'specific', 'criteria', 'as', 'suggested', 'by', 'the', 'last', 'American', 'Thoracic', 'Society', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'ATS', 'IDSA', 'guidelines', 'However', 'clinical', 'practice', 'and', 'recent', 'literature', 'have', 'suggested', 'new', 'risk', 'factors', 'for', 'multidrug', 'resistant', 'infection', 'MRI', 'the', 'presence', 'of', 'permanent', 'indwelling', 'devices', 'prior', 'antibiotic', 'use', 'in', 'the', 'last', '3', 'months', 'chronic', 'and', 'advanced', 'pulmonary', 'diseases', 'chronic', 'obstructive', 'pulmonary', 'disease', 'bronchiectasis', 'etc', 'history', 'of', 'alcoholism', 'and', 'immunosuppression', 'The', 'clinical', 'presentation', 'in', 'HCAP', 'patients', 'is', 'often', 'unusual', 'mild', 'respiratory', 'symptoms', 'and', 'frequent', 'extrapulmonary', 'manifestations', 'due', 'to', 'different', 'factors', 'advanced', 'age', 'neurological', 'disorders', 'and', 'multiple', 'chronic', 'comorbidities', 'Moreover', 'HCAP', 'commonly', 'presents', 'a', 'worse', 'clinical', 'course', 'than', 'community', 'acquired', 'pneumonia', 'a', 'prolonged', 'length', 'of', 'stay', 'and', 'a', 'mortality', 'rate', 'close', 'to', 'hospital', 'acquired', 'pneumonia', 'Chest', 'radiography', 'and', 'routine', 'laboratory', 'markers', 'including', 'C', 'reactive', 'protein', 'are', 'always', 'needed', 'for', 'clinical', 'evaluation', 'and', 'severity', 'assessment', 'The', 'clinical', 'use', 'of', 'new', 'biomarkers', 'of', 'infection', 'and', 'sepsis', 'procalcitonin', 'etc', 'is', 'currently', 'being', 'investigated', 'Extensive', 'microbiological', 'testing', 'to', 'overcome', 'the', 'high', 'prevalence', 'of', 'MRI', 'in', 'HCAP', 'including', 'urinary', 'antigens', 'for', 'Legionella', 'and', 'Streptococcus', 'pneumoniae', 'blood', 'cultures', 'Gram', 'staining', 'and', 'low', 'respiratory', 'tract', 'secretions', 'sputum', 'tracheobronchial', 'aspirate', 'fibrobronchial', 'aspirate', 'protected', 'specimen', 'brush', 'bronchoalveolar', 'lavage', 'and', 'cultures', 'for', 'aerobic', 'anaerobic', 'mycobacterial', 'and', 'fungal', 'pathogens', 'are', 'recommended', 'whereas', 'the', 'indication', 'for', 'serology', 'tests', 'for', 'respiratory', 'viruses', 'and', 'atypical', 'pathogens', 'is', 'low', 'By', 'contrast', 'the', 'new', 'polymerase', 'chain', 'reaction', 'based', 'techniques', 'for', 'the', 'rapid', 'identification', '2', 'to', '4', 'hours', 'of', 'microbial', 'pathogens', 'in', 'respiratory', 'samples', 'nasopharyngeal', 'swab', 'bronchoalveolar', 'lavage', 'seem', 'to', 'be', 'the', 'most', 'innovative', 'future', 'perspective', 'in', 'the', 'diagnostics', 'of', 'HCAP', '']"
71667,Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment.,2020-04-29,,http://medrxiv.org/cgi/content/short/2020.04.23.20077156v1?rss=1,"The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a comprehensive comparison of serological COVID-19 assays. We show that the assay detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, had optimal characteristics for antibody detection in different stages of disease.",10.1101/2020.04.23.20077156,nxy21x7k,"['The', 'world', 'is', 'entering', 'a', 'new', 'era', 'of', 'the', 'COVID', '19', 'pandemic', 'in', 'which', 'there', 'is', 'an', 'increasing', 'call', 'for', 'reliable', 'antibody', 'testing', 'To', 'support', 'decision', 'making', 'on', 'the', 'deployment', 'of', 'serology', 'for', 'either', 'population', 'screening', 'or', 'diagnostics', 'we', 'present', 'a', 'comprehensive', 'comparison', 'of', 'serological', 'COVID', '19', 'assays', 'We', 'show', 'that', 'the', 'assay', 'detecting', 'total', 'immunoglobulins', 'against', 'the', 'receptor', 'binding', 'domain', 'of', 'SARS', 'CoV', '2', 'had', 'optimal', 'characteristics', 'for', 'antibody', 'detection', 'in', 'different', 'stages', 'of', 'disease', '']"
72632,"Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products",2020-06-29,,http://medrxiv.org/cgi/content/short/2020.06.25.20140236v1?rss=1,"As the United States prepares to return to work and open up the economy in the midst of the COVID-19 pandemic without an available vaccine or effective therapy, testing and contact tracing are essential to contain and limit the spread of the COVID-19 virus. In response to the urgent public health need for accurate, effective, low-cost, and scalable COVID-19 testing technology, we evaluated and identified diagnostic solutions with potential for use as an at-home product. We conducted a deep horizon scan for antigen and serology-based diagnostics and down-selected to the most promising technologies. A total of 303 candidate products (138 antibody and 44 antigen tests) were identified. Product evaluations were based entirely on company-provided data. 73 serology-based antibody tests passing an initial scoring algorithm based on specificity and sensitivity data were then further evaluated using a second scoring algorithm. This second algorithm included a review of additional technical specifications of the devices, an analysis of supply chain, manufacturing, and distribution capacity of each vendor. 24 potential antibody products met the selection criteria for further direct laboratory evaluation. The performance metrics for selection of these 24 products are currently being evaluated in a Mass General Brigham laboratory. Testing alone might not be sufficient to prevent the spread of a highly contagious disease like COVID-19. Manual contact tracing could complement testing, but it is likely to fail in identifying many individuals who were in contact with a given COVID patient. The proliferation of smartphones in the population has enabled the development of solutions that can provide public health officials with valuable information for rapid and accurate contact tracing. Besides, electronic-based contact tracing solutions can be augmented by symptom self-reports gathered using electronic patient reported outcome (ePRO) platforms and by physiological data collected using wearable sensors. We performed a detailed assessment of 12 ePRO solutions, 27 wearable sensors, and 44 electronic-based contact tracing solutions. These technologies were evaluated using criteria developed to assess their suitability to address the COVID-19 pandemic. We identified a number of solutions that could augment if not provide a more effective alternative to manual contact tracing. Finally, we propose a theoretical framework in which ePRO platforms, wearable sensors, and electronic-based contact tracing solutions would be utilized in combination with molecular and serological tests to identify and isolate COVID-19 cases rapidly.",10.1101/2020.06.25.20140236,hz3z6xkk,"['As', 'the', 'United', 'States', 'prepares', 'to', 'return', 'to', 'work', 'and', 'open', 'up', 'the', 'economy', 'in', 'the', 'midst', 'of', 'the', 'COVID', '19', 'pandemic', 'without', 'an', 'available', 'vaccine', 'or', 'effective', 'therapy', 'testing', 'and', 'contact', 'tracing', 'are', 'essential', 'to', 'contain', 'and', 'limit', 'the', 'spread', 'of', 'the', 'COVID', '19', 'virus', 'In', 'response', 'to', 'the', 'urgent', 'public', 'health', 'need', 'for', 'accurate', 'effective', 'low', 'cost', 'and', 'scalable', 'COVID', '19', 'testing', 'technology', 'we', 'evaluated', 'and', 'identified', 'diagnostic', 'solutions', 'with', 'potential', 'for', 'use', 'as', 'an', 'at', 'home', 'product', 'We', 'conducted', 'a', 'deep', 'horizon', 'scan', 'for', 'antigen', 'and', 'serology', 'based', 'diagnostics', 'and', 'down', 'selected', 'to', 'the', 'most', 'promising', 'technologies', 'A', 'total', 'of', '303', 'candidate', 'products', '138', 'antibody', 'and', '44', 'antigen', 'tests', 'were', 'identified', 'Product', 'evaluations', 'were', 'based', 'entirely', 'on', 'company', 'provided', 'data', '73', 'serology', 'based', 'antibody', 'tests', 'passing', 'an', 'initial', 'scoring', 'algorithm', 'based', 'on', 'specificity', 'and', 'sensitivity', 'data', 'were', 'then', 'further', 'evaluated', 'using', 'a', 'second', 'scoring', 'algorithm', 'This', 'second', 'algorithm', 'included', 'a', 'review', 'of', 'additional', 'technical', 'specifications', 'of', 'the', 'devices', 'an', 'analysis', 'of', 'supply', 'chain', 'manufacturing', 'and', 'distribution', 'capacity', 'of', 'each', 'vendor', '24', 'potential', 'antibody', 'products', 'met', 'the', 'selection', 'criteria', 'for', 'further', 'direct', 'laboratory', 'evaluation', 'The', 'performance', 'metrics', 'for', 'selection', 'of', 'these', '24', 'products', 'are', 'currently', 'being', 'evaluated', 'in', 'a', 'Mass', 'General', 'Brigham', 'laboratory', 'Testing', 'alone', 'might', 'not', 'be', 'sufficient', 'to', 'prevent', 'the', 'spread', 'of', 'a', 'highly', 'contagious', 'disease', 'like', 'COVID', '19', 'Manual', 'contact', 'tracing', 'could', 'complement', 'testing', 'but', 'it', 'is', 'likely', 'to', 'fail', 'in', 'identifying', 'many', 'individuals', 'who', 'were', 'in', 'contact', 'with', 'a', 'given', 'COVID', 'patient', 'The', 'proliferation', 'of', 'smartphones', 'in', 'the', 'population', 'has', 'enabled', 'the', 'development', 'of', 'solutions', 'that', 'can', 'provide', 'public', 'health', 'officials', 'with', 'valuable', 'information', 'for', 'rapid', 'and', 'accurate', 'contact', 'tracing', 'Besides', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'can', 'be', 'augmented', 'by', 'symptom', 'self', 'reports', 'gathered', 'using', 'electronic', 'patient', 'reported', 'outcome', 'ePRO', 'platforms', 'and', 'by', 'physiological', 'data', 'collected', 'using', 'wearable', 'sensors', 'We', 'performed', 'a', 'detailed', 'assessment', 'of', '12', 'ePRO', 'solutions', '27', 'wearable', 'sensors', 'and', '44', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'These', 'technologies', 'were', 'evaluated', 'using', 'criteria', 'developed', 'to', 'assess', 'their', 'suitability', 'to', 'address', 'the', 'COVID', '19', 'pandemic', 'We', 'identified', 'a', 'number', 'of', 'solutions', 'that', 'could', 'augment', 'if', 'not', 'provide', 'a', 'more', 'effective', 'alternative', 'to', 'manual', 'contact', 'tracing', 'Finally', 'we', 'propose', 'a', 'theoretical', 'framework', 'in', 'which', 'ePRO', 'platforms', 'wearable', 'sensors', 'and', 'electronic', 'based', 'contact', 'tracing', 'solutions', 'would', 'be', 'utilized', 'in', 'combination', 'with', 'molecular', 'and', 'serological', 'tests', 'to', 'identify', 'and', 'isolate', 'COVID', '19', 'cases', 'rapidly', '']"
75514,"Distinct systems serology features in children, elderly and COVID patients",2020-05-18,,http://medrxiv.org/cgi/content/short/2020.05.11.20098459v1?rss=1,"SARS-CoV-2, the pandemic coronavirus that causes COVID-19, has infected millions worldwide, causing unparalleled social and economic disruptions. COVID-19 results in higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive coronavirus immunological responses, induced by circulating human coronaviruses, is critical to understand such divergent clinical outcomes. The cross-reactivity of coronavirus antibody responses of healthy children (n=89), adults (n=98), elderly (n=57), and COVID-19 patients (n=19) were analysed by systems serology. While moderate levels of cross-reactive SARS-CoV-2 IgG, IgM, and IgA were detected in healthy individuals, we identified serological signatures associated with SARS-CoV-2 antigen-specific Fc{gamma} receptor binding, which accurately distinguished COVID-19 patients from healthy individuals and suggested that SARS-CoV-2 induces qualitative changes to antibody Fc upon infection, enhancing Fc{gamma} receptor engagement. Vastly different serological signatures were observed between healthy children and elderly, with markedly higher cross-reactive SARS-CoV-2 IgA and IgG observed in elderly, whereas children displayed elevated SARS-CoV-2 IgM, including receptor binding domain-specific IgM with higher avidity. These results suggest that less-experienced humoral immunity associated with higher IgM, as observed in children, may have the potential to induce more potent antibodies upon SARS-CoV-2 infection. These key insights will inform COVID-19 vaccination strategies, improved serological diagnostics and therapeutics.",10.1101/2020.05.11.20098459,8nbmrjrw,"['SARS', 'CoV', '2', 'the', 'pandemic', 'coronavirus', 'that', 'causes', 'COVID', '19', 'has', 'infected', 'millions', 'worldwide', 'causing', 'unparalleled', 'social', 'and', 'economic', 'disruptions', 'COVID', '19', 'results', 'in', 'higher', 'pathogenicity', 'and', 'mortality', 'in', 'the', 'elderly', 'compared', 'to', 'children', 'Examining', 'baseline', 'SARS', 'CoV', '2', 'cross', 'reactive', 'coronavirus', 'immunological', 'responses', 'induced', 'by', 'circulating', 'human', 'coronaviruses', 'is', 'critical', 'to', 'understand', 'such', 'divergent', 'clinical', 'outcomes', 'The', 'cross', 'reactivity', 'of', 'coronavirus', 'antibody', 'responses', 'of', 'healthy', 'children', 'n', '89', 'adults', 'n', '98', 'elderly', 'n', '57', 'and', 'COVID', '19', 'patients', 'n', '19', 'were', 'analysed', 'by', 'systems', 'serology', 'While', 'moderate', 'levels', 'of', 'cross', 'reactive', 'SARS', 'CoV', '2', 'IgG', 'IgM', 'and', 'IgA', 'were', 'detected', 'in', 'healthy', 'individuals', 'we', 'identified', 'serological', 'signatures', 'associated', 'with', 'SARS', 'CoV', '2', 'antigen', 'specific', 'Fc', 'gamma', 'receptor', 'binding', 'which', 'accurately', 'distinguished', 'COVID', '19', 'patients', 'from', 'healthy', 'individuals', 'and', 'suggested', 'that', 'SARS', 'CoV', '2', 'induces', 'qualitative', 'changes', 'to', 'antibody', 'Fc', 'upon', 'infection', 'enhancing', 'Fc', 'gamma', 'receptor', 'engagement', 'Vastly', 'different', 'serological', 'signatures', 'were', 'observed', 'between', 'healthy', 'children', 'and', 'elderly', 'with', 'markedly', 'higher', 'cross', 'reactive', 'SARS', 'CoV', '2', 'IgA', 'and', 'IgG', 'observed', 'in', 'elderly', 'whereas', 'children', 'displayed', 'elevated', 'SARS', 'CoV', '2', 'IgM', 'including', 'receptor', 'binding', 'domain', 'specific', 'IgM', 'with', 'higher', 'avidity', 'These', 'results', 'suggest', 'that', 'less', 'experienced', 'humoral', 'immunity', 'associated', 'with', 'higher', 'IgM', 'as', 'observed', 'in', 'children', 'may', 'have', 'the', 'potential', 'to', 'induce', 'more', 'potent', 'antibodies', 'upon', 'SARS', 'CoV', '2', 'infection', 'These', 'key', 'insights', 'will', 'inform', 'COVID', '19', 'vaccination', 'strategies', 'improved', 'serological', 'diagnostics', 'and', 'therapeutics', '']"
76548,Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic,2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20085068v1?rss=1,"ABSTRACT Background: Antibody diagnostics play an important role in disease detection and can potentially aid in monitoring of the immune responses to see if an individual has developed immunity. Developing high throughput diagnostics which does not involve handling of infectious material becomes imperative in the case of pandemics such as the recent outbreak of SARS-CoV2. Methods: A protein microarray technology was used to detect the plurality of antibody response to four novel antigens namely S1 glycoprotein, Receptor binding domain (RBD), S2 glycoprotein and Nucleoprotein of the novel coronavirus named SARS-CoV2 using serum samples. A DBS card was additionally used to compare its performance with a venipuncture-based serum separator tube (SST) draw. Results: The three main subclasses of antibodies IgM, IgA and IgG were analyzed to see the variations in immune responses in the affected population and compared to their microbial RT-PCR based NP swab results. The clinical sensitivity and specificity were determined to be 98.1% and 98.6%. In the matrix comparison study, which would enable patients to test without risk of transmitting the virus, DBS matched with higher than 98% accuracy to a venipuncture-based SST collection. Conclusion: Multiplex testing enables higher sensitivity and specificity which is essential while establishing exposure on a population scale. This flexible platform along with a discrete collection methodology would be crucial and broadly useful to scale up testing in current and future pandemics. Minimum sample volume that can be collected using DBS cards can be processed in this multiplex pillar plate format enabling the capacity to provide the reliability of high throughput analyzers while having the ease of collection similar to rapid tests. Keywords: COVID19, SARS-CoV2, Antibody, Multiplex, serology, biomarker, immune modulation, prevalence, high sensitivity, high specificity, Dried blood spot, pandemic, venipuncture",10.1101/2020.04.29.20085068,8uu10t4p,"['ABSTRACT', 'Background', 'Antibody', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'disease', 'detection', 'and', 'can', 'potentially', 'aid', 'in', 'monitoring', 'of', 'the', 'immune', 'responses', 'to', 'see', 'if', 'an', 'individual', 'has', 'developed', 'immunity', 'Developing', 'high', 'throughput', 'diagnostics', 'which', 'does', 'not', 'involve', 'handling', 'of', 'infectious', 'material', 'becomes', 'imperative', 'in', 'the', 'case', 'of', 'pandemics', 'such', 'as', 'the', 'recent', 'outbreak', 'of', 'SARS', 'CoV2', 'Methods', 'A', 'protein', 'microarray', 'technology', 'was', 'used', 'to', 'detect', 'the', 'plurality', 'of', 'antibody', 'response', 'to', 'four', 'novel', 'antigens', 'namely', 'S1', 'glycoprotein', 'Receptor', 'binding', 'domain', 'RBD', 'S2', 'glycoprotein', 'and', 'Nucleoprotein', 'of', 'the', 'novel', 'coronavirus', 'named', 'SARS', 'CoV2', 'using', 'serum', 'samples', 'A', 'DBS', 'card', 'was', 'additionally', 'used', 'to', 'compare', 'its', 'performance', 'with', 'a', 'venipuncture', 'based', 'serum', 'separator', 'tube', 'SST', 'draw', 'Results', 'The', 'three', 'main', 'subclasses', 'of', 'antibodies', 'IgM', 'IgA', 'and', 'IgG', 'were', 'analyzed', 'to', 'see', 'the', 'variations', 'in', 'immune', 'responses', 'in', 'the', 'affected', 'population', 'and', 'compared', 'to', 'their', 'microbial', 'RT', 'PCR', 'based', 'NP', 'swab', 'results', 'The', 'clinical', 'sensitivity', 'and', 'specificity', 'were', 'determined', 'to', 'be', '98', '1', 'and', '98', '6', 'In', 'the', 'matrix', 'comparison', 'study', 'which', 'would', 'enable', 'patients', 'to', 'test', 'without', 'risk', 'of', 'transmitting', 'the', 'virus', 'DBS', 'matched', 'with', 'higher', 'than', '98', 'accuracy', 'to', 'a', 'venipuncture', 'based', 'SST', 'collection', 'Conclusion', 'Multiplex', 'testing', 'enables', 'higher', 'sensitivity', 'and', 'specificity', 'which', 'is', 'essential', 'while', 'establishing', 'exposure', 'on', 'a', 'population', 'scale', 'This', 'flexible', 'platform', 'along', 'with', 'a', 'discrete', 'collection', 'methodology', 'would', 'be', 'crucial', 'and', 'broadly', 'useful', 'to', 'scale', 'up', 'testing', 'in', 'current', 'and', 'future', 'pandemics', 'Minimum', 'sample', 'volume', 'that', 'can', 'be', 'collected', 'using', 'DBS', 'cards', 'can', 'be', 'processed', 'in', 'this', 'multiplex', 'pillar', 'plate', 'format', 'enabling', 'the', 'capacity', 'to', 'provide', 'the', 'reliability', 'of', 'high', 'throughput', 'analyzers', 'while', 'having', 'the', 'ease', 'of', 'collection', 'similar', 'to', 'rapid', 'tests', 'Keywords', 'COVID19', 'SARS', 'CoV2', 'Antibody', 'Multiplex', 'serology', 'biomarker', 'immune', 'modulation', 'prevalence', 'high', 'sensitivity', 'high', 'specificity', 'Dried', 'blood', 'spot', 'pandemic', 'venipuncture']"
77228,A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds,2020-06-05,bioRxiv,https://doi.org/10.1101/2020.06.05.135806,"The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge. Constituting important correlates of protection, determination of virus-neutralizing antibodies (NAbs) is indispensable for convalescent plasma selection, vaccine candidate evaluation, and immunity certificates. In contrast to standard serology ELISAs, plaque reduction neutralization tests (PRNTs) are laborious, time-consuming, expensive, and restricted to specialized laboratories. To replace microscopic counting-based SARS-CoV-2 PRNTs by a novel assay exempt from genetically modified viruses, which are inapplicable in most diagnostics departments, we established a simple, rapid, and automated SARS-CoV-2 neutralization assay employing an in-cell ELISA (icELISA) approach. After optimization of various parameters such as virus-specific antibodies, cell lines, virus doses, and duration of infection, SARS-CoV-2-infected cells became amenable as direct antigen source for quantitative icELISA. Using commercially available nucleocapsid protein-specific antibodies, viral infection could easily be quantified in human and highly permissive Vero E6 cells by icELISA. Antiviral agents such as human sera containing NAbs or antiviral interferons dose-dependently reduced the SARS-CoV-2-specific signal. Applying increased infectious doses, the icNT was superior to PRNT in discriminating convalescent sera with high from those with intermediate neutralizing capacities. The SARS-CoV-2 icELISA test allows rapid (<48h in total, read-out in seconds) and automated quantification of virus infection in cell culture to evaluate the efficacy of NAbs as well as antiviral drugs, using reagents and equipment present in most routine diagnostics departments. We propose the icELISA and the icNT for COVID-19 research and diagnostics.",10.1101/2020.06.05.135806,grs1zpag,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'currently', 'the', 'most', 'pressing', 'medical', 'and', 'socioeconomic', 'challenge', 'Constituting', 'important', 'correlates', 'of', 'protection', 'determination', 'of', 'virus', 'neutralizing', 'antibodies', 'NAbs', 'is', 'indispensable', 'for', 'convalescent', 'plasma', 'selection', 'vaccine', 'candidate', 'evaluation', 'and', 'immunity', 'certificates', 'In', 'contrast', 'to', 'standard', 'serology', 'ELISAs', 'plaque', 'reduction', 'neutralization', 'tests', 'PRNTs', 'are', 'laborious', 'time', 'consuming', 'expensive', 'and', 'restricted', 'to', 'specialized', 'laboratories', 'To', 'replace', 'microscopic', 'counting', 'based', 'SARS', 'CoV', '2', 'PRNTs', 'by', 'a', 'novel', 'assay', 'exempt', 'from', 'genetically', 'modified', 'viruses', 'which', 'are', 'inapplicable', 'in', 'most', 'diagnostics', 'departments', 'we', 'established', 'a', 'simple', 'rapid', 'and', 'automated', 'SARS', 'CoV', '2', 'neutralization', 'assay', 'employing', 'an', 'in', 'cell', 'ELISA', 'icELISA', 'approach', 'After', 'optimization', 'of', 'various', 'parameters', 'such', 'as', 'virus', 'specific', 'antibodies', 'cell', 'lines', 'virus', 'doses', 'and', 'duration', 'of', 'infection', 'SARS', 'CoV', '2', 'infected', 'cells', 'became', 'amenable', 'as', 'direct', 'antigen', 'source', 'for', 'quantitative', 'icELISA', 'Using', 'commercially', 'available', 'nucleocapsid', 'protein', 'specific', 'antibodies', 'viral', 'infection', 'could', 'easily', 'be', 'quantified', 'in', 'human', 'and', 'highly', 'permissive', 'Vero', 'E6', 'cells', 'by', 'icELISA', 'Antiviral', 'agents', 'such', 'as', 'human', 'sera', 'containing', 'NAbs', 'or', 'antiviral', 'interferons', 'dose', 'dependently', 'reduced', 'the', 'SARS', 'CoV', '2', 'specific', 'signal', 'Applying', 'increased', 'infectious', 'doses', 'the', 'icNT', 'was', 'superior', 'to', 'PRNT', 'in', 'discriminating', 'convalescent', 'sera', 'with', 'high', 'from', 'those', 'with', 'intermediate', 'neutralizing', 'capacities', 'The', 'SARS', 'CoV', '2', 'icELISA', 'test', 'allows', 'rapid', '48h', 'in', 'total', 'read', 'out', 'in', 'seconds', 'and', 'automated', 'quantification', 'of', 'virus', 'infection', 'in', 'cell', 'culture', 'to', 'evaluate', 'the', 'efficacy', 'of', 'NAbs', 'as', 'well', 'as', 'antiviral', 'drugs', 'using', 'reagents', 'and', 'equipment', 'present', 'in', 'most', 'routine', 'diagnostics', 'departments', 'We', 'propose', 'the', 'icELISA', 'and', 'the', 'icNT', 'for', 'COVID', '19', 'research', 'and', 'diagnostics', '']"
80697,A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood,2020-07-02,,http://medrxiv.org/cgi/content/short/2020.07.01.20143966v1?rss=1,"The COVID-19 pandemic has posed a tremendous challenge for the global community. We established a translational approach combining home blood sampling by finger-pricking with multiplexed serology to assess the exposure to the SARS-CoV-2 virus in a general population. The developed procedure determines the immune response in multiplexed assays against several spike (S, here denoted SPK), receptor binding domain (RBD) and nucleocapsid (NCP) proteins in eluates from dried capillary blood. The seroprevalence was then determined in two study sets by mailing 1000 blood sampling kits to random households in urban Stockholm during early and late April 2020, respectively. After receiving 55% (1097/2000) of the cards back within three weeks, 80% (878/1097) were suitable for the analyses of IgG and IgM titers. The data revealed diverse pattern of immune response, thus seroprevalence was dependent on the antigen, immunoglobulin class, stringency to include different antigens, as well as the required analytical performance. Applying unsupervised dimensionality reduction to the combined IgG and IgM data, 4.4% (19/435; 95% CI: 2.4%-6.3%) and 6.3% (28/443; 95% CI: 4.1%-8.6%) of the samples clustered with convalescent controls. Using overlapping scores from at least two SPK antigens, prevalence rates reached 10.1% (44/435; 95% CI: 7.3%-12.9%) in study set 1 and 10.8% (48/443; 95% CI: 7.9%-13.7%). Measuring the immune response against several SARS-CoV-2 proteins in a multiplexed workflow can provide valuable insights about the serological diversity and improve the certainty of the classification. Combining such assays with home-sampling of blood presents a viable strategy for individual-level diagnostics and towards an unbiased assessment of the seroprevalence in a population and may serve to improve our understanding about the diversity of COVID-19 etiology.",10.1101/2020.07.01.20143966,pnz9zkdz,"['The', 'COVID', '19', 'pandemic', 'has', 'posed', 'a', 'tremendous', 'challenge', 'for', 'the', 'global', 'community', 'We', 'established', 'a', 'translational', 'approach', 'combining', 'home', 'blood', 'sampling', 'by', 'finger', 'pricking', 'with', 'multiplexed', 'serology', 'to', 'assess', 'the', 'exposure', 'to', 'the', 'SARS', 'CoV', '2', 'virus', 'in', 'a', 'general', 'population', 'The', 'developed', 'procedure', 'determines', 'the', 'immune', 'response', 'in', 'multiplexed', 'assays', 'against', 'several', 'spike', 'S', 'here', 'denoted', 'SPK', 'receptor', 'binding', 'domain', 'RBD', 'and', 'nucleocapsid', 'NCP', 'proteins', 'in', 'eluates', 'from', 'dried', 'capillary', 'blood', 'The', 'seroprevalence', 'was', 'then', 'determined', 'in', 'two', 'study', 'sets', 'by', 'mailing', '1000', 'blood', 'sampling', 'kits', 'to', 'random', 'households', 'in', 'urban', 'Stockholm', 'during', 'early', 'and', 'late', 'April', '2020', 'respectively', 'After', 'receiving', '55', '1097', '2000', 'of', 'the', 'cards', 'back', 'within', 'three', 'weeks', '80', '878', '1097', 'were', 'suitable', 'for', 'the', 'analyses', 'of', 'IgG', 'and', 'IgM', 'titers', 'The', 'data', 'revealed', 'diverse', 'pattern', 'of', 'immune', 'response', 'thus', 'seroprevalence', 'was', 'dependent', 'on', 'the', 'antigen', 'immunoglobulin', 'class', 'stringency', 'to', 'include', 'different', 'antigens', 'as', 'well', 'as', 'the', 'required', 'analytical', 'performance', 'Applying', 'unsupervised', 'dimensionality', 'reduction', 'to', 'the', 'combined', 'IgG', 'and', 'IgM', 'data', '4', '4', '19', '435', '95', 'CI', '2', '4', '6', '3', 'and', '6', '3', '28', '443', '95', 'CI', '4', '1', '8', '6', 'of', 'the', 'samples', 'clustered', 'with', 'convalescent', 'controls', 'Using', 'overlapping', 'scores', 'from', 'at', 'least', 'two', 'SPK', 'antigens', 'prevalence', 'rates', 'reached', '10', '1', '44', '435', '95', 'CI', '7', '3', '12', '9', 'in', 'study', 'set', '1', 'and', '10', '8', '48', '443', '95', 'CI', '7', '9', '13', '7', 'Measuring', 'the', 'immune', 'response', 'against', 'several', 'SARS', 'CoV', '2', 'proteins', 'in', 'a', 'multiplexed', 'workflow', 'can', 'provide', 'valuable', 'insights', 'about', 'the', 'serological', 'diversity', 'and', 'improve', 'the', 'certainty', 'of', 'the', 'classification', 'Combining', 'such', 'assays', 'with', 'home', 'sampling', 'of', 'blood', 'presents', 'a', 'viable', 'strategy', 'for', 'individual', 'level', 'diagnostics', 'and', 'towards', 'an', 'unbiased', 'assessment', 'of', 'the', 'seroprevalence', 'in', 'a', 'population', 'and', 'may', 'serve', 'to', 'improve', 'our', 'understanding', 'about', 'the', 'diversity', 'of', 'COVID', '19', 'etiology', '']"
82654,Nucleocapsid protein-based enzyme-linked immunosorbent assay for detection and differentiation of antibodies against European and North American porcine reproductive and respiratory syndrome virus.,2002,Clinical and diagnostic laboratory immunology,https://www.ncbi.nlm.nih.gov/pubmed/12414748/,"Two types of porcine reproductive and respiratory syndrome virus (PRRSV) have been reported, the European type (EU PRRSV) and the North American type (US PRRSV). We developed a dual enzyme-linked immunosorbent assay (ELISA) for the simultaneous detection and differentiation of serum antibodies directed against either of the two PRRSV types. This tandem PRRS ELISA is based on affinity-purified recombinant nucleocapsid protein expressed in Escherichia coli. Sensitivity and specificity were assessed by using the IDEXX HerdChek PRRS ELISA and the indirect immunofluorescence assay as reference tests. A total of 1571 sera originating from the United States, Europe, and two PRRS-free countries, i.e., Switzerland and New Zealand, were used for validation of the tandem PRRS ELISA. The new test performed at least as well as the reference tests in regard to sensitivity (0.94 for the US PRRS ELISA and 0.93 for the EU PRRS ELISA) and specificity (0.96 for the US PRRS ELISA and 0.99 for the EU PRRS ELISA). Positive sera were correctly differentiated in 582 of 591 cases, indicating a high differentiation capability of this dual ELISA. The robustness and repeatability of the test were assessed and found to be appropriate for diagnostic applications. Taken together, the data indicate that the tandem PRRS ELISA described here is the first differentiation ELISA for PRRSV serology based on recombinant antigen. It is convenient with respect to antigen production, and it is reliable, economical, and highly sensitive and specific. Thus, it is considered to be a powerful tool for routine diagnostics, epidemiological surveys, and outbreak investigations.",,lr9gb0sb,"['Two', 'types', 'of', 'porcine', 'reproductive', 'and', 'respiratory', 'syndrome', 'virus', 'PRRSV', 'have', 'been', 'reported', 'the', 'European', 'type', 'EU', 'PRRSV', 'and', 'the', 'North', 'American', 'type', 'US', 'PRRSV', 'We', 'developed', 'a', 'dual', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'for', 'the', 'simultaneous', 'detection', 'and', 'differentiation', 'of', 'serum', 'antibodies', 'directed', 'against', 'either', 'of', 'the', 'two', 'PRRSV', 'types', 'This', 'tandem', 'PRRS', 'ELISA', 'is', 'based', 'on', 'affinity', 'purified', 'recombinant', 'nucleocapsid', 'protein', 'expressed', 'in', 'Escherichia', 'coli', 'Sensitivity', 'and', 'specificity', 'were', 'assessed', 'by', 'using', 'the', 'IDEXX', 'HerdChek', 'PRRS', 'ELISA', 'and', 'the', 'indirect', 'immunofluorescence', 'assay', 'as', 'reference', 'tests', 'A', 'total', 'of', '1571', 'sera', 'originating', 'from', 'the', 'United', 'States', 'Europe', 'and', 'two', 'PRRS', 'free', 'countries', 'i', 'e', 'Switzerland', 'and', 'New', 'Zealand', 'were', 'used', 'for', 'validation', 'of', 'the', 'tandem', 'PRRS', 'ELISA', 'The', 'new', 'test', 'performed', 'at', 'least', 'as', 'well', 'as', 'the', 'reference', 'tests', 'in', 'regard', 'to', 'sensitivity', '0', '94', 'for', 'the', 'US', 'PRRS', 'ELISA', 'and', '0', '93', 'for', 'the', 'EU', 'PRRS', 'ELISA', 'and', 'specificity', '0', '96', 'for', 'the', 'US', 'PRRS', 'ELISA', 'and', '0', '99', 'for', 'the', 'EU', 'PRRS', 'ELISA', 'Positive', 'sera', 'were', 'correctly', 'differentiated', 'in', '582', 'of', '591', 'cases', 'indicating', 'a', 'high', 'differentiation', 'capability', 'of', 'this', 'dual', 'ELISA', 'The', 'robustness', 'and', 'repeatability', 'of', 'the', 'test', 'were', 'assessed', 'and', 'found', 'to', 'be', 'appropriate', 'for', 'diagnostic', 'applications', 'Taken', 'together', 'the', 'data', 'indicate', 'that', 'the', 'tandem', 'PRRS', 'ELISA', 'described', 'here', 'is', 'the', 'first', 'differentiation', 'ELISA', 'for', 'PRRSV', 'serology', 'based', 'on', 'recombinant', 'antigen', 'It', 'is', 'convenient', 'with', 'respect', 'to', 'antigen', 'production', 'and', 'it', 'is', 'reliable', 'economical', 'and', 'highly', 'sensitive', 'and', 'specific', 'Thus', 'it', 'is', 'considered', 'to', 'be', 'a', 'powerful', 'tool', 'for', 'routine', 'diagnostics', 'epidemiological', 'surveys', 'and', 'outbreak', 'investigations', '']"
84471,Human bocavirus.,2008,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,https://www.ncbi.nlm.nih.gov/pubmed/18055252/,"Human bocavirus (HBoV) was first described in 2005 in nasopharyngeal aspirates of children with respiratory tract infection. Multiple studies have confirmed the presence of HBoV in respiratory tract samples of children world-wide. HBoV has recently also been detected in blood and fecal samples. Most studies so far have studied virus prevalence, and only a few reports provide data regarding the linkage of HBoV to disease. These reports indicate that HBoV infection is indeed associated with acute respiratory tract symptoms, but also that HBoV may persist in the respiratory tract for a longer time than other respiratory agents, resulting in frequent detection of low load HBoV carriage. This phenomenon has complicated the use of PCR diagnostics, which has been the only available diagnostic method. Development of alternative diagnostic strategies such as serology will be important for future studies of HBoV and its association with disease.",,7y62fq1u,"['Human', 'bocavirus', 'HBoV', 'was', 'first', 'described', 'in', '2005', 'in', 'nasopharyngeal', 'aspirates', 'of', 'children', 'with', 'respiratory', 'tract', 'infection', 'Multiple', 'studies', 'have', 'confirmed', 'the', 'presence', 'of', 'HBoV', 'in', 'respiratory', 'tract', 'samples', 'of', 'children', 'world', 'wide', 'HBoV', 'has', 'recently', 'also', 'been', 'detected', 'in', 'blood', 'and', 'fecal', 'samples', 'Most', 'studies', 'so', 'far', 'have', 'studied', 'virus', 'prevalence', 'and', 'only', 'a', 'few', 'reports', 'provide', 'data', 'regarding', 'the', 'linkage', 'of', 'HBoV', 'to', 'disease', 'These', 'reports', 'indicate', 'that', 'HBoV', 'infection', 'is', 'indeed', 'associated', 'with', 'acute', 'respiratory', 'tract', 'symptoms', 'but', 'also', 'that', 'HBoV', 'may', 'persist', 'in', 'the', 'respiratory', 'tract', 'for', 'a', 'longer', 'time', 'than', 'other', 'respiratory', 'agents', 'resulting', 'in', 'frequent', 'detection', 'of', 'low', 'load', 'HBoV', 'carriage', 'This', 'phenomenon', 'has', 'complicated', 'the', 'use', 'of', 'PCR', 'diagnostics', 'which', 'has', 'been', 'the', 'only', 'available', 'diagnostic', 'method', 'Development', 'of', 'alternative', 'diagnostic', 'strategies', 'such', 'as', 'serology', 'will', 'be', 'important', 'for', 'future', 'studies', 'of', 'HBoV', 'and', 'its', 'association', 'with', 'disease', '']"
86712,The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.,2004,The Clinical biochemist. Reviews,https://www.ncbi.nlm.nih.gov/pubmed/18458711/,"The 2003 pandemic of Severe Acute Respiratory Syndrome (SARS) profiled the ability of modern diagnostic microbiology and molecular biology to identify, isolate and characterize, within weeks, a previously unknown viral infectious pathogen. The culprit, SARS coronavirus (SARS-CoV), was detected in patient specimens by traditional cell culture using an unusual cell line for respiratory viruses, Vero E6, and by reverse transcriptase polymerase chain reaction (RT-PCR) targeting the polymerase 1 B region of the genome. In addition, serologic assays were rapidly developed, and the genome of this large virus was sequenced within one month of its spread to North America. At the present time, diagnostics have progressed to the point that RT-PCR has a sensitivity approaching 80% within the first few days of onset of illness, while serology has a sensitivity close to 100% on convalescent sera taken >21 days after illness onset. Viral culture remains a method confined to biosafety level III laboratories. The specificity of RT-PCR and serology remains to be conclusively defined, but in most studies to date seems to be >90%. Serologic cross-reactivity with human coronaviruses causing the common cold may be a problem with some serologic assays. The early development of SARS-CoV diagnostics is now being replaced by refinement and optimization of these assays. Although at the present time we do not have a test that will definitively rule in or rule out SARS at the time of initial presentation of a patient with a respiratory infection, modifications of existing assays will hopefully result in our ability to make this diagnosis with a high degree of accuracy in the future.",,ycch15k8,"['The', '2003', 'pandemic', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'profiled', 'the', 'ability', 'of', 'modern', 'diagnostic', 'microbiology', 'and', 'molecular', 'biology', 'to', 'identify', 'isolate', 'and', 'characterize', 'within', 'weeks', 'a', 'previously', 'unknown', 'viral', 'infectious', 'pathogen', 'The', 'culprit', 'SARS', 'coronavirus', 'SARS', 'CoV', 'was', 'detected', 'in', 'patient', 'specimens', 'by', 'traditional', 'cell', 'culture', 'using', 'an', 'unusual', 'cell', 'line', 'for', 'respiratory', 'viruses', 'Vero', 'E6', 'and', 'by', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'targeting', 'the', 'polymerase', '1', 'B', 'region', 'of', 'the', 'genome', 'In', 'addition', 'serologic', 'assays', 'were', 'rapidly', 'developed', 'and', 'the', 'genome', 'of', 'this', 'large', 'virus', 'was', 'sequenced', 'within', 'one', 'month', 'of', 'its', 'spread', 'to', 'North', 'America', 'At', 'the', 'present', 'time', 'diagnostics', 'have', 'progressed', 'to', 'the', 'point', 'that', 'RT', 'PCR', 'has', 'a', 'sensitivity', 'approaching', '80', 'within', 'the', 'first', 'few', 'days', 'of', 'onset', 'of', 'illness', 'while', 'serology', 'has', 'a', 'sensitivity', 'close', 'to', '100', 'on', 'convalescent', 'sera', 'taken', '21', 'days', 'after', 'illness', 'onset', 'Viral', 'culture', 'remains', 'a', 'method', 'confined', 'to', 'biosafety', 'level', 'III', 'laboratories', 'The', 'specificity', 'of', 'RT', 'PCR', 'and', 'serology', 'remains', 'to', 'be', 'conclusively', 'defined', 'but', 'in', 'most', 'studies', 'to', 'date', 'seems', 'to', 'be', '90', 'Serologic', 'cross', 'reactivity', 'with', 'human', 'coronaviruses', 'causing', 'the', 'common', 'cold', 'may', 'be', 'a', 'problem', 'with', 'some', 'serologic', 'assays', 'The', 'early', 'development', 'of', 'SARS', 'CoV', 'diagnostics', 'is', 'now', 'being', 'replaced', 'by', 'refinement', 'and', 'optimization', 'of', 'these', 'assays', 'Although', 'at', 'the', 'present', 'time', 'we', 'do', 'not', 'have', 'a', 'test', 'that', 'will', 'definitively', 'rule', 'in', 'or', 'rule', 'out', 'SARS', 'at', 'the', 'time', 'of', 'initial', 'presentation', 'of', 'a', 'patient', 'with', 'a', 'respiratory', 'infection', 'modifications', 'of', 'existing', 'assays', 'will', 'hopefully', 'result', 'in', 'our', 'ability', 'to', 'make', 'this', 'diagnosis', 'with', 'a', 'high', 'degree', 'of', 'accuracy', 'in', 'the', 'future', '']"
91015,Advances in the laboratory diagnosis of viral respiratory disease.,2004,The Pediatric infectious disease journal,https://www.ncbi.nlm.nih.gov/pubmed/14730264/,"BACKGROUND In recent years significant advances in the laboratory diagnostics available to detect respiratory viral infections have been achieved. METHODS This article presents the types of diagnostic methods currently available to the practitioner, as well as those on the horizon. The article covers tissue culture, serology and direct examination as well as some rapid diagnostic techniques and molecular assays, previewing developing new technology. CONCLUSIONS Laboratory diagnosis will likely be clinically useful in some but not all cases of viral infection. As new diagnostic methods become widely available, it is increasingly important to develop guidelines for laboratory testing when viral illness is suspected.",,1c1oe7tg,"['BACKGROUND', 'In', 'recent', 'years', 'significant', 'advances', 'in', 'the', 'laboratory', 'diagnostics', 'available', 'to', 'detect', 'respiratory', 'viral', 'infections', 'have', 'been', 'achieved', 'METHODS', 'This', 'article', 'presents', 'the', 'types', 'of', 'diagnostic', 'methods', 'currently', 'available', 'to', 'the', 'practitioner', 'as', 'well', 'as', 'those', 'on', 'the', 'horizon', 'The', 'article', 'covers', 'tissue', 'culture', 'serology', 'and', 'direct', 'examination', 'as', 'well', 'as', 'some', 'rapid', 'diagnostic', 'techniques', 'and', 'molecular', 'assays', 'previewing', 'developing', 'new', 'technology', 'CONCLUSIONS', 'Laboratory', 'diagnosis', 'will', 'likely', 'be', 'clinically', 'useful', 'in', 'some', 'but', 'not', 'all', 'cases', 'of', 'viral', 'infection', 'As', 'new', 'diagnostic', 'methods', 'become', 'widely', 'available', 'it', 'is', 'increasingly', 'important', 'to', 'develop', 'guidelines', 'for', 'laboratory', 'testing', 'when', 'viral', 'illness', 'is', 'suspected', '']"
93520,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois",2020,Curr. opin. rheumatol,,"BACKGROUND: Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM: Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY: In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW: Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",,m7y37ue6,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
93521,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois",2020,Curr. opin. rheumatol,,"BACKGROUND: Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM: Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY: In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW: Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",,llf0iqop,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
106203,COVID-19 pandemic-a focused review for clinicians,2020,Clin Microbiol Infect,,"BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019, and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. OBJECTIVES: Here we provide an update for clinicians on the recent developments in the virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. SOURCES: We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. CONTENT: We describe the virological characteristics of SARS-CoV-2 and the clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. IMPLICATIONS: The key challenge in managing COVID-19 remains patient density. However, accurate diagnosis as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",,f33f0868,"['BACKGROUND', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'OBJECTIVES', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'in', 'the', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'SOURCES', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'CONTENT', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'the', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'IMPLICATIONS', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'patient', 'density', 'However', 'accurate', 'diagnosis', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
114213,Serology testing in the COVID-19 pandemic response,2020,Lancet infect. dis,,"The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.",,rrxloui4,"['The', 'collapse', 'of', 'global', 'cooperation', 'and', 'a', 'failure', 'of', 'international', 'solidarity', 'have', 'led', 'to', 'many', 'low', 'income', 'and', 'middle', 'income', 'countries', 'being', 'denied', 'access', 'to', 'molecular', 'diagnostics', 'in', 'the', 'COVID', '19', 'pandemic', 'response', 'Yet', 'the', 'scarcity', 'of', 'knowledge', 'on', 'the', 'dynamics', 'of', 'the', 'immune', 'response', 'to', 'infection', 'has', 'led', 'to', 'hesitation', 'on', 'recommending', 'the', 'use', 'of', 'rapid', 'immunodiagnostic', 'tests', 'even', 'though', 'rapid', 'serology', 'tests', 'are', 'commercially', 'available', 'and', 'scalable', 'On', 'the', 'basis', 'of', 'our', 'knowledge', 'and', 'understanding', 'of', 'viral', 'infectivity', 'and', 'host', 'response', 'we', 'urge', 'countries', 'without', 'the', 'capacity', 'to', 'do', 'molecular', 'testing', 'at', 'scale', 'to', 'research', 'the', 'use', 'of', 'serology', 'tests', 'to', 'triage', 'symptomatic', 'patients', 'in', 'community', 'settings', 'to', 'test', 'contacts', 'of', 'confirmed', 'cases', 'and', 'in', 'situational', 'analysis', 'and', 'surveillance', 'The', 'WHO', 'R', 'D', 'Blue', 'Print', 'expert', 'group', 'identified', 'eight', 'priorities', 'for', 'research', 'and', 'development', 'of', 'which', 'the', 'highest', 'is', 'to', 'mobilise', 'research', 'on', 'rapid', 'point', 'of', 'care', 'diagnostics', 'for', 'use', 'at', 'the', 'community', 'level', 'This', 'research', 'should', 'inform', 'control', 'programmes', 'of', 'the', 'required', 'performance', 'and', 'utility', 'of', 'rapid', 'serology', 'tests', 'which', 'when', 'applied', 'specifically', 'for', 'appropriate', 'public', 'health', 'measures', 'to', 'then', 'be', 'put', 'in', 'place', 'can', 'make', 'a', 'huge', 'difference', '']"
116783,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management,2020,IEEE reviews in biomedical engineering (Online),,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",,kawhus2f,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
116784,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management,2020,,,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",,ye44fr72,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
127400,An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment,2020,Nat Commun,,"The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a detailed comparison of serological COVID-19 assays. We show that among the selected assays there is a wide diversity in assay performance in different scenarios and when correlated to virus neutralizing antibodies. The Wantai ELISA detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, has the best overall characteristics to detect functional antibodies in different stages and severity of disease, including the potential to set a cut-off indicating the presence of protective antibodies. The large variety of available serological assays requires proper assay validation before deciding on deployment of assays for specific applications.",,cv2dg9tg,"['The', 'world', 'is', 'entering', 'a', 'new', 'era', 'of', 'the', 'COVID', '19', 'pandemic', 'in', 'which', 'there', 'is', 'an', 'increasing', 'call', 'for', 'reliable', 'antibody', 'testing', 'To', 'support', 'decision', 'making', 'on', 'the', 'deployment', 'of', 'serology', 'for', 'either', 'population', 'screening', 'or', 'diagnostics', 'we', 'present', 'a', 'detailed', 'comparison', 'of', 'serological', 'COVID', '19', 'assays', 'We', 'show', 'that', 'among', 'the', 'selected', 'assays', 'there', 'is', 'a', 'wide', 'diversity', 'in', 'assay', 'performance', 'in', 'different', 'scenarios', 'and', 'when', 'correlated', 'to', 'virus', 'neutralizing', 'antibodies', 'The', 'Wantai', 'ELISA', 'detecting', 'total', 'immunoglobulins', 'against', 'the', 'receptor', 'binding', 'domain', 'of', 'SARS', 'CoV', '2', 'has', 'the', 'best', 'overall', 'characteristics', 'to', 'detect', 'functional', 'antibodies', 'in', 'different', 'stages', 'and', 'severity', 'of', 'disease', 'including', 'the', 'potential', 'to', 'set', 'a', 'cut', 'off', 'indicating', 'the', 'presence', 'of', 'protective', 'antibodies', 'The', 'large', 'variety', 'of', 'available', 'serological', 'assays', 'requires', 'proper', 'assay', 'validation', 'before', 'deciding', 'on', 'deployment', 'of', 'assays', 'for', 'specific', 'applications', '']"
133633,COVID-19 Clinical Diagnostics and Testing Technology,2020,Pharmacotherapy,,"Given the global nature of the COVID-19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS-CoV-2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID-19 diagnostics on the horizon. Antibody response against SARS-CoV-2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",,afcd4wc9,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
146845,An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment,2020-07-06,Nat Commun,https://www.ncbi.nlm.nih.gov/pubmed/32632160/; https://doi.org/10.1038/s41467-020-17317-y,"The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a detailed comparison of serological COVID-19 assays. We show that among the selected assays there is a wide diversity in assay performance in different scenarios and when correlated to virus neutralizing antibodies. The Wantai ELISA detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, has the best overall characteristics to detect functional antibodies in different stages and severity of disease, including the potential to set a cut-off indicating the presence of protective antibodies. The large variety of available serological assays requires proper assay validation before deciding on deployment of assays for specific applications.",10.1038/s41467-020-17317-y,jeedo5mc,"['The', 'world', 'is', 'entering', 'a', 'new', 'era', 'of', 'the', 'COVID', '19', 'pandemic', 'in', 'which', 'there', 'is', 'an', 'increasing', 'call', 'for', 'reliable', 'antibody', 'testing', 'To', 'support', 'decision', 'making', 'on', 'the', 'deployment', 'of', 'serology', 'for', 'either', 'population', 'screening', 'or', 'diagnostics', 'we', 'present', 'a', 'detailed', 'comparison', 'of', 'serological', 'COVID', '19', 'assays', 'We', 'show', 'that', 'among', 'the', 'selected', 'assays', 'there', 'is', 'a', 'wide', 'diversity', 'in', 'assay', 'performance', 'in', 'different', 'scenarios', 'and', 'when', 'correlated', 'to', 'virus', 'neutralizing', 'antibodies', 'The', 'Wantai', 'ELISA', 'detecting', 'total', 'immunoglobulins', 'against', 'the', 'receptor', 'binding', 'domain', 'of', 'SARS', 'CoV', '2', 'has', 'the', 'best', 'overall', 'characteristics', 'to', 'detect', 'functional', 'antibodies', 'in', 'different', 'stages', 'and', 'severity', 'of', 'disease', 'including', 'the', 'potential', 'to', 'set', 'a', 'cut', 'off', 'indicating', 'the', 'presence', 'of', 'protective', 'antibodies', 'The', 'large', 'variety', 'of', 'available', 'serological', 'assays', 'requires', 'proper', 'assay', 'validation', 'before', 'deciding', 'on', 'deployment', 'of', 'assays', 'for', 'specific', 'applications', '']"
149075,Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies,2012-09-27,Med Clin North Am,https://www.ncbi.nlm.nih.gov/pubmed/23102477/; https://doi.org/10.1016/j.mcna.2012.08.005; https://api.elsevier.com/content/article/pii/S0025712512001538; https://www.sciencedirect.com/science/article/pii/S0025712512001538,"Clinical laboratories have traditionally relied on time-consuming phenotypic methods such as culture, serology, and biochemical tests for detection, identification, and characterization of microbial pathogens. Real-time polymerase chain reaction technology can now identify many pathogenic organisms that constitute infectious disease emergencies in normal and immune-compromised hosts. Use of this molecular technology for the accurate diagnosis of infectious disease agents by clinical laboratories reduces the time to diagnosis for many pathogens. This article is designed such that the clinician evaluating a patient with severe acute illness can reference the most relevant molecular diagnostics available pertinent to the predominant organ system involved.",10.1016/j.mcna.2012.08.005,jw8hqei0,"['Clinical', 'laboratories', 'have', 'traditionally', 'relied', 'on', 'time', 'consuming', 'phenotypic', 'methods', 'such', 'as', 'culture', 'serology', 'and', 'biochemical', 'tests', 'for', 'detection', 'identification', 'and', 'characterization', 'of', 'microbial', 'pathogens', 'Real', 'time', 'polymerase', 'chain', 'reaction', 'technology', 'can', 'now', 'identify', 'many', 'pathogenic', 'organisms', 'that', 'constitute', 'infectious', 'disease', 'emergencies', 'in', 'normal', 'and', 'immune', 'compromised', 'hosts', 'Use', 'of', 'this', 'molecular', 'technology', 'for', 'the', 'accurate', 'diagnosis', 'of', 'infectious', 'disease', 'agents', 'by', 'clinical', 'laboratories', 'reduces', 'the', 'time', 'to', 'diagnosis', 'for', 'many', 'pathogens', 'This', 'article', 'is', 'designed', 'such', 'that', 'the', 'clinician', 'evaluating', 'a', 'patient', 'with', 'severe', 'acute', 'illness', 'can', 'reference', 'the', 'most', 'relevant', 'molecular', 'diagnostics', 'available', 'pertinent', 'to', 'the', 'predominant', 'organ', 'system', 'involved', '']"
151210,Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics,2020-06-26,Diagnostics (Basel),https://doi.org/10.3390/diagnostics10060434; https://www.ncbi.nlm.nih.gov/pubmed/32604919/,"Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.",10.3390/diagnostics10060434,tb1zsuw4,"['Validated', 'and', 'accurate', 'laboratory', 'testing', 'for', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'crucial', 'part', 'of', 'the', 'timely', 'management', 'of', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'disease', 'supporting', 'the', 'clinical', 'decision', 'making', 'process', 'for', 'infection', 'control', 'at', 'the', 'healthcare', 'level', 'and', 'detecting', 'asymptomatic', 'cases', 'This', 'would', 'facilitate', 'an', 'appropriate', 'treatment', 'a', 'prompt', 'isolation', 'and', 'consequently', 'deceleration', 'of', 'the', 'pandemic', 'Various', 'laboratory', 'tests', 'can', 'identify', 'the', 'genetic', 'material', 'of', 'SARS', 'CoV', '2', 'that', 'causes', 'COVID', '19', 'in', 'specimens', 'or', 'specific', 'anti', 'viral', 'antibodies', 'in', 'blood', 'serum', 'Due', 'to', 'the', 'current', 'pandemic', 'situation', 'a', 'development', 'of', 'point', 'of', 'care', 'diagnostics', 'POCD', 'allows', 'us', 'to', 'substantially', 'accelerate', 'taking', 'clinical', 'decisions', 'and', 'implement', 'strategic', 'planning', 'at', 'the', 'national', 'level', 'of', 'preventative', 'measures', 'This', 'review', 'summarizes', 'and', 'compares', 'the', 'available', 'POCD', 'and', 'those', 'currently', 'under', 'development', 'including', 'quantitative', 'reverse', 'transcription', 'PCR', 'RT', 'qPCR', 'serology', 'immunoassays', 'SIAs', 'and', 'protein', 'microarray', 'method', 'PMM', 'designed', 'for', 'standard', 'and', 'rapid', 'COVID', '19', 'diagnosis', '']"
153784,COVID-19 pandemic – A focused review for clinicians,2020-04-25,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/32344166/; https://www.sciencedirect.com/science/article/pii/S1198743X20302317?v=s5; https://api.elsevier.com/content/article/pii/S1198743X20302317; https://doi.org/10.1016/j.cmi.2020.04.023,"Abstract Background The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, economics and society. A wealth of data has been generated since its emergence in December 2019 and it is vital for clinicians to keep up with this data from across the world at a time of uncertainty and constantly evolving guidelines and clinical practice. Objectives Here we provide an update for clinicians on the recent developments about virology, diagnostics, clinical presentation, viral shedding, and treatment options for COVID-19 based on current literature. Sources We considered published peer-reviewed papers and non-peer-reviewed pre-print manuscripts on COVID19 and related aspects with an emphasis on clinical management aspects. Content We describe the virological characteristics of SARS-CoV-2 and clinical course of COVID-19 with an emphasis on diagnostic challenges, duration of viral shedding, severity markers and current treatment options. Implications The key challenge in managing COVID-19 remains the patient density. However, accurate diagnoses as well as early identification and management of high-risk severe cases are important for many clinicians. For improved management of cases, there is a need to understand test probability of serology, qRT-PCR and radiological testing, and the efficacy of available treatment options that could be used in severe cases with a high risk of mortality.",10.1016/j.cmi.2020.04.023,x64tii2t,"['Abstract', 'Background', 'The', 'COVID', '19', 'pandemic', 'caused', 'by', 'SARS', 'CoV', '2', 'remains', 'a', 'significant', 'issue', 'for', 'global', 'health', 'economics', 'and', 'society', 'A', 'wealth', 'of', 'data', 'has', 'been', 'generated', 'since', 'its', 'emergence', 'in', 'December', '2019', 'and', 'it', 'is', 'vital', 'for', 'clinicians', 'to', 'keep', 'up', 'with', 'this', 'data', 'from', 'across', 'the', 'world', 'at', 'a', 'time', 'of', 'uncertainty', 'and', 'constantly', 'evolving', 'guidelines', 'and', 'clinical', 'practice', 'Objectives', 'Here', 'we', 'provide', 'an', 'update', 'for', 'clinicians', 'on', 'the', 'recent', 'developments', 'about', 'virology', 'diagnostics', 'clinical', 'presentation', 'viral', 'shedding', 'and', 'treatment', 'options', 'for', 'COVID', '19', 'based', 'on', 'current', 'literature', 'Sources', 'We', 'considered', 'published', 'peer', 'reviewed', 'papers', 'and', 'non', 'peer', 'reviewed', 'pre', 'print', 'manuscripts', 'on', 'COVID19', 'and', 'related', 'aspects', 'with', 'an', 'emphasis', 'on', 'clinical', 'management', 'aspects', 'Content', 'We', 'describe', 'the', 'virological', 'characteristics', 'of', 'SARS', 'CoV', '2', 'and', 'clinical', 'course', 'of', 'COVID', '19', 'with', 'an', 'emphasis', 'on', 'diagnostic', 'challenges', 'duration', 'of', 'viral', 'shedding', 'severity', 'markers', 'and', 'current', 'treatment', 'options', 'Implications', 'The', 'key', 'challenge', 'in', 'managing', 'COVID', '19', 'remains', 'the', 'patient', 'density', 'However', 'accurate', 'diagnoses', 'as', 'well', 'as', 'early', 'identification', 'and', 'management', 'of', 'high', 'risk', 'severe', 'cases', 'are', 'important', 'for', 'many', 'clinicians', 'For', 'improved', 'management', 'of', 'cases', 'there', 'is', 'a', 'need', 'to', 'understand', 'test', 'probability', 'of', 'serology', 'qRT', 'PCR', 'and', 'radiological', 'testing', 'and', 'the', 'efficacy', 'of', 'available', 'treatment', 'options', 'that', 'could', 'be', 'used', 'in', 'severe', 'cases', 'with', 'a', 'high', 'risk', 'of', 'mortality', '']"
159254,Current Trends in Diagnostics of Viral Infections of Unknown Etiology,2020-02-14,Viruses,https://doi.org/10.3390/v12020211; https://www.ncbi.nlm.nih.gov/pubmed/32074965/,"Viruses are evolving at an alarming rate, spreading and inconspicuously adapting to cutting-edge therapies. Therefore, the search for rapid, informative and reliable diagnostic methods is becoming urgent as ever. Conventional clinical tests (PCR, serology, etc.) are being continually optimized, yet provide very limited data. Could high throughput sequencing (HTS) become the future gold standard in molecular diagnostics of viral infections? Compared to conventional clinical tests, HTS is universal and more precise at profiling pathogens. Nevertheless, it has not yet been widely accepted as a diagnostic tool, owing primarily to its high cost and the complexity of sample preparation and data analysis. Those obstacles must be tackled to integrate HTS into daily clinical practice. For this, three objectives are to be achieved: (1) designing and assessing universal protocols for library preparation, (2) assembling purpose-specific pipelines, and (3) building computational infrastructure to suit the needs and financial abilities of modern healthcare centers. Data harvested with HTS could not only augment diagnostics and help to choose the correct therapy, but also facilitate research in epidemiology, genetics and virology. This information, in turn, could significantly aid clinicians in battling viral infections.",10.3390/v12020211,u2n8so5w,"['Viruses', 'are', 'evolving', 'at', 'an', 'alarming', 'rate', 'spreading', 'and', 'inconspicuously', 'adapting', 'to', 'cutting', 'edge', 'therapies', 'Therefore', 'the', 'search', 'for', 'rapid', 'informative', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'becoming', 'urgent', 'as', 'ever', 'Conventional', 'clinical', 'tests', 'PCR', 'serology', 'etc', 'are', 'being', 'continually', 'optimized', 'yet', 'provide', 'very', 'limited', 'data', 'Could', 'high', 'throughput', 'sequencing', 'HTS', 'become', 'the', 'future', 'gold', 'standard', 'in', 'molecular', 'diagnostics', 'of', 'viral', 'infections', 'Compared', 'to', 'conventional', 'clinical', 'tests', 'HTS', 'is', 'universal', 'and', 'more', 'precise', 'at', 'profiling', 'pathogens', 'Nevertheless', 'it', 'has', 'not', 'yet', 'been', 'widely', 'accepted', 'as', 'a', 'diagnostic', 'tool', 'owing', 'primarily', 'to', 'its', 'high', 'cost', 'and', 'the', 'complexity', 'of', 'sample', 'preparation', 'and', 'data', 'analysis', 'Those', 'obstacles', 'must', 'be', 'tackled', 'to', 'integrate', 'HTS', 'into', 'daily', 'clinical', 'practice', 'For', 'this', 'three', 'objectives', 'are', 'to', 'be', 'achieved', '1', 'designing', 'and', 'assessing', 'universal', 'protocols', 'for', 'library', 'preparation', '2', 'assembling', 'purpose', 'specific', 'pipelines', 'and', '3', 'building', 'computational', 'infrastructure', 'to', 'suit', 'the', 'needs', 'and', 'financial', 'abilities', 'of', 'modern', 'healthcare', 'centers', 'Data', 'harvested', 'with', 'HTS', 'could', 'not', 'only', 'augment', 'diagnostics', 'and', 'help', 'to', 'choose', 'the', 'correct', 'therapy', 'but', 'also', 'facilitate', 'research', 'in', 'epidemiology', 'genetics', 'and', 'virology', 'This', 'information', 'in', 'turn', 'could', 'significantly', 'aid', 'clinicians', 'in', 'battling', 'viral', 'infections', '']"
162222,Difficulty with mumps diagnosis: What is the contribution of mumps mimickers?,2009-12-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653209004624; https://doi.org/10.1016/j.jcv.2009.09.024; https://api.elsevier.com/content/article/pii/S1386653209004624; https://www.ncbi.nlm.nih.gov/pubmed/19828368/,"Abstract Background Mumps is a vaccine preventable disease that typically presents with unilateral or bilateral parotitis. In February 2007, mumps re-emerged in university students in Nova Scotia. Despite highly sensitive methods for mumps virus detection, only 14% (298/2082) of cases during the peak of the outbreak were laboratory confirmed. Objectives Due to the low positivity rate, this study investigated whether infection with other viral pathogens caused mumps-like presentations during the outbreak. Study design 148 buccal specimens from patients who presented with unilateral or bilateral parotitis but had negative laboratory tests for mumps virus were tested for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) by quantitative PCR and 21 different viral markers using the Luminex xTAG Respiratory Virus Panel (RVP). Companion sera to each buccal specimen were available for EBV and CMV serology to differentiate acute infection from reactivation. Results No correlation was observed since viral pathogens were detected in both the parotitis and non-parotitis groups. Conclusion Although there was co-circulation of other viral pathogens during the mumps outbreak, no difference was observed in the prevalence between patients who presented with or without parotitis. The low positivity rate for specimens submitted for mumps diagnostics was likely the result of increased Public Health messaging and physician inexperience in recognizing mumps infection, suggesting the clinical acumen for mumps diagnosis based solely on clinical presentation is low.",10.1016/j.jcv.2009.09.024,ion8wr2l,"['Abstract', 'Background', 'Mumps', 'is', 'a', 'vaccine', 'preventable', 'disease', 'that', 'typically', 'presents', 'with', 'unilateral', 'or', 'bilateral', 'parotitis', 'In', 'February', '2007', 'mumps', 're', 'emerged', 'in', 'university', 'students', 'in', 'Nova', 'Scotia', 'Despite', 'highly', 'sensitive', 'methods', 'for', 'mumps', 'virus', 'detection', 'only', '14', '298', '2082', 'of', 'cases', 'during', 'the', 'peak', 'of', 'the', 'outbreak', 'were', 'laboratory', 'confirmed', 'Objectives', 'Due', 'to', 'the', 'low', 'positivity', 'rate', 'this', 'study', 'investigated', 'whether', 'infection', 'with', 'other', 'viral', 'pathogens', 'caused', 'mumps', 'like', 'presentations', 'during', 'the', 'outbreak', 'Study', 'design', '148', 'buccal', 'specimens', 'from', 'patients', 'who', 'presented', 'with', 'unilateral', 'or', 'bilateral', 'parotitis', 'but', 'had', 'negative', 'laboratory', 'tests', 'for', 'mumps', 'virus', 'were', 'tested', 'for', 'Epstein', 'Barr', 'virus', 'EBV', 'and', 'cytomegalovirus', 'CMV', 'by', 'quantitative', 'PCR', 'and', '21', 'different', 'viral', 'markers', 'using', 'the', 'Luminex', 'xTAG', 'Respiratory', 'Virus', 'Panel', 'RVP', 'Companion', 'sera', 'to', 'each', 'buccal', 'specimen', 'were', 'available', 'for', 'EBV', 'and', 'CMV', 'serology', 'to', 'differentiate', 'acute', 'infection', 'from', 'reactivation', 'Results', 'No', 'correlation', 'was', 'observed', 'since', 'viral', 'pathogens', 'were', 'detected', 'in', 'both', 'the', 'parotitis', 'and', 'non', 'parotitis', 'groups', 'Conclusion', 'Although', 'there', 'was', 'co', 'circulation', 'of', 'other', 'viral', 'pathogens', 'during', 'the', 'mumps', 'outbreak', 'no', 'difference', 'was', 'observed', 'in', 'the', 'prevalence', 'between', 'patients', 'who', 'presented', 'with', 'or', 'without', 'parotitis', 'The', 'low', 'positivity', 'rate', 'for', 'specimens', 'submitted', 'for', 'mumps', 'diagnostics', 'was', 'likely', 'the', 'result', 'of', 'increased', 'Public', 'Health', 'messaging', 'and', 'physician', 'inexperience', 'in', 'recognizing', 'mumps', 'infection', 'suggesting', 'the', 'clinical', 'acumen', 'for', 'mumps', 'diagnosis', 'based', 'solely', 'on', 'clinical', 'presentation', 'is', 'low', '']"
163393,Global outbreak research: harmony not hegemony,2020-06-02,Lancet Infect Dis,https://www.sciencedirect.com/science/article/pii/S1473309920304400; https://www.ncbi.nlm.nih.gov/pubmed/32502433/; https://api.elsevier.com/content/article/pii/S1473309920304400; https://doi.org/10.1016/s1473-3099(20)30440-0,"[ ]perhaps it is self-evident that harmonisation of clinical investigation during outbreaks is desirable In 2016, the ISARIC/WHO CCP was implemented in Brazil in response to the emergence of Zika virus and chikungunya virus in Latin America, facilitating studies of viral shedding and serology 2 The CCP was also used for the establishment of cohort studies of critically ill patients with Middle East respiratory syndrome 3 At present, the Uganda Virus Research Institute (Entebbe, Uganda) is using the protocol to study severe acute febrile illness and severe influenza 4 The value of this approach is becoming apparent in the age of COVID-19 The original reports on clinical findings in COVID-19 used harmonised data collection 5,6 46 countries have registered to record clinical data using the ISARIC/WHO CCP Case Report Form and investigators in many countries are planning to use the CCP biological sampling protocol to coordinate studies of transmission, prognostication, pathogenesis, and diagnostics (appendix)",10.1016/s1473-3099(20)30440-0,99rjqsh6,"['', 'perhaps', 'it', 'is', 'self', 'evident', 'that', 'harmonisation', 'of', 'clinical', 'investigation', 'during', 'outbreaks', 'is', 'desirable', 'In', '2016', 'the', 'ISARIC', 'WHO', 'CCP', 'was', 'implemented', 'in', 'Brazil', 'in', 'response', 'to', 'the', 'emergence', 'of', 'Zika', 'virus', 'and', 'chikungunya', 'virus', 'in', 'Latin', 'America', 'facilitating', 'studies', 'of', 'viral', 'shedding', 'and', 'serology', '2', 'The', 'CCP', 'was', 'also', 'used', 'for', 'the', 'establishment', 'of', 'cohort', 'studies', 'of', 'critically', 'ill', 'patients', 'with', 'Middle', 'East', 'respiratory', 'syndrome', '3', 'At', 'present', 'the', 'Uganda', 'Virus', 'Research', 'Institute', 'Entebbe', 'Uganda', 'is', 'using', 'the', 'protocol', 'to', 'study', 'severe', 'acute', 'febrile', 'illness', 'and', 'severe', 'influenza', '4', 'The', 'value', 'of', 'this', 'approach', 'is', 'becoming', 'apparent', 'in', 'the', 'age', 'of', 'COVID', '19', 'The', 'original', 'reports', 'on', 'clinical', 'findings', 'in', 'COVID', '19', 'used', 'harmonised', 'data', 'collection', '5', '6', '46', 'countries', 'have', 'registered', 'to', 'record', 'clinical', 'data', 'using', 'the', 'ISARIC', 'WHO', 'CCP', 'Case', 'Report', 'Form', 'and', 'investigators', 'in', 'many', 'countries', 'are', 'planning', 'to', 'use', 'the', 'CCP', 'biological', 'sampling', 'protocol', 'to', 'coordinate', 'studies', 'of', 'transmission', 'prognostication', 'pathogenesis', 'and', 'diagnostics', 'appendix', '']"
168601,Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE): protocol for a multisite prospective observational study of the causes of fever in Africa and Asia,2020-07-21,BMJ Open,https://doi.org/10.1136/bmjopen-2019-035632; https://www.ncbi.nlm.nih.gov/pubmed/32699131/,"INTRODUCTION: Fever commonly leads to healthcare seeking and hospital admission in sub-Saharan Africa and Asia. There is only limited guidance for clinicians managing non-malarial fevers, which often results in inappropriate treatment for patients. Furthermore, there is little evidence for estimates of disease burden, or to guide empirical therapy, control measures, resource allocation, prioritisation of clinical diagnostics or antimicrobial stewardship. The Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE) study seeks to address these information gaps. METHODS AND ANALYSIS: FIEBRE investigates febrile illness in paediatric and adult outpatients and inpatients using standardised clinical, laboratory and social science protocols over a minimum 12-month period at five sites in sub-Saharan Africa and Southeastern and Southern Asia. Patients presenting with fever are enrolled and provide clinical data, pharyngeal swabs and a venous blood sample; selected participants also provide a urine sample. Laboratory assessments target infections that are treatable and/or preventable. Selected point-of-care tests, as well as blood and urine cultures and antimicrobial susceptibility testing, are performed on site. On day 28, patients provide a second venous blood sample for serology and information on clinical outcome. Further diagnostic assays are performed at international reference laboratories. Blood and pharyngeal samples from matched community controls enable calculation of AFs, and surveys of treatment seeking allow estimation of the incidence of common infections. Additional assays detect markers that may differentiate bacterial from non-bacterial causes of illness and/or prognosticate illness severity. Social science research on antimicrobial use will inform future recommendations for fever case management. Residual samples from participants are stored for future use. ETHICS AND DISSEMINATION: Ethics approval was obtained from all relevant institutional and national committees; written informed consent is obtained from all participants or parents/guardians. Final results will be shared with participating communities, and in open-access journals and other scientific fora. Study documents are available online (https://doi.org/10.17037/PUBS.04652739).",10.1136/bmjopen-2019-035632,g7vxhpx2,"['INTRODUCTION', 'Fever', 'commonly', 'leads', 'to', 'healthcare', 'seeking', 'and', 'hospital', 'admission', 'in', 'sub', 'Saharan', 'Africa', 'and', 'Asia', 'There', 'is', 'only', 'limited', 'guidance', 'for', 'clinicians', 'managing', 'non', 'malarial', 'fevers', 'which', 'often', 'results', 'in', 'inappropriate', 'treatment', 'for', 'patients', 'Furthermore', 'there', 'is', 'little', 'evidence', 'for', 'estimates', 'of', 'disease', 'burden', 'or', 'to', 'guide', 'empirical', 'therapy', 'control', 'measures', 'resource', 'allocation', 'prioritisation', 'of', 'clinical', 'diagnostics', 'or', 'antimicrobial', 'stewardship', 'The', 'Febrile', 'Illness', 'Evaluation', 'in', 'a', 'Broad', 'Range', 'of', 'Endemicities', 'FIEBRE', 'study', 'seeks', 'to', 'address', 'these', 'information', 'gaps', 'METHODS', 'AND', 'ANALYSIS', 'FIEBRE', 'investigates', 'febrile', 'illness', 'in', 'paediatric', 'and', 'adult', 'outpatients', 'and', 'inpatients', 'using', 'standardised', 'clinical', 'laboratory', 'and', 'social', 'science', 'protocols', 'over', 'a', 'minimum', '12', 'month', 'period', 'at', 'five', 'sites', 'in', 'sub', 'Saharan', 'Africa', 'and', 'Southeastern', 'and', 'Southern', 'Asia', 'Patients', 'presenting', 'with', 'fever', 'are', 'enrolled', 'and', 'provide', 'clinical', 'data', 'pharyngeal', 'swabs', 'and', 'a', 'venous', 'blood', 'sample', 'selected', 'participants', 'also', 'provide', 'a', 'urine', 'sample', 'Laboratory', 'assessments', 'target', 'infections', 'that', 'are', 'treatable', 'and', 'or', 'preventable', 'Selected', 'point', 'of', 'care', 'tests', 'as', 'well', 'as', 'blood', 'and', 'urine', 'cultures', 'and', 'antimicrobial', 'susceptibility', 'testing', 'are', 'performed', 'on', 'site', 'On', 'day', '28', 'patients', 'provide', 'a', 'second', 'venous', 'blood', 'sample', 'for', 'serology', 'and', 'information', 'on', 'clinical', 'outcome', 'Further', 'diagnostic', 'assays', 'are', 'performed', 'at', 'international', 'reference', 'laboratories', 'Blood', 'and', 'pharyngeal', 'samples', 'from', 'matched', 'community', 'controls', 'enable', 'calculation', 'of', 'AFs', 'and', 'surveys', 'of', 'treatment', 'seeking', 'allow', 'estimation', 'of', 'the', 'incidence', 'of', 'common', 'infections', 'Additional', 'assays', 'detect', 'markers', 'that', 'may', 'differentiate', 'bacterial', 'from', 'non', 'bacterial', 'causes', 'of', 'illness', 'and', 'or', 'prognosticate', 'illness', 'severity', 'Social', 'science', 'research', 'on', 'antimicrobial', 'use', 'will', 'inform', 'future', 'recommendations', 'for', 'fever', 'case', 'management', 'Residual', 'samples', 'from', 'participants', 'are', 'stored', 'for', 'future', 'use', 'ETHICS', 'AND', 'DISSEMINATION', 'Ethics', 'approval', 'was', 'obtained', 'from', 'all', 'relevant', 'institutional', 'and', 'national', 'committees', 'written', 'informed', 'consent', 'is', 'obtained', 'from', 'all', 'participants', 'or', 'parents', 'guardians', 'Final', 'results', 'will', 'be', 'shared', 'with', 'participating', 'communities', 'and', 'in', 'open', 'access', 'journals', 'and', 'other', 'scientific', 'fora', 'Study', 'documents', 'are', 'available', 'online', 'https', 'doi', 'org', '10', '17037', 'PUBS', '04652739', '']"
184092,Serology testing in the COVID-19 pandemic response,2020-07-17,Lancet Infect Dis,https://api.elsevier.com/content/article/pii/S147330992030517X; https://www.sciencedirect.com/science/article/pii/S147330992030517X; https://www.ncbi.nlm.nih.gov/pubmed/32687805/; https://doi.org/10.1016/s1473-3099(20)30517-x,"The collapse of global cooperation and a failure of international solidarity have led to many low-income and middle-income countries being denied access to molecular diagnostics in the COVID-19 pandemic response. Yet the scarcity of knowledge on the dynamics of the immune response to infection has led to hesitation on recommending the use of rapid immunodiagnostic tests, even though rapid serology tests are commercially available and scalable. On the basis of our knowledge and understanding of viral infectivity and host response, we urge countries without the capacity to do molecular testing at scale to research the use of serology tests to triage symptomatic patients in community settings, to test contacts of confirmed cases, and in situational analysis and surveillance. The WHO R&D Blue Print expert group identified eight priorities for research and development, of which the highest is to mobilise research on rapid point-of-care diagnostics for use at the community level. This research should inform control programmes of the required performance and utility of rapid serology tests, which, when applied specifically for appropriate public health measures to then be put in place, can make a huge difference.",10.1016/s1473-3099(20)30517-x,ru2iw0py,"['The', 'collapse', 'of', 'global', 'cooperation', 'and', 'a', 'failure', 'of', 'international', 'solidarity', 'have', 'led', 'to', 'many', 'low', 'income', 'and', 'middle', 'income', 'countries', 'being', 'denied', 'access', 'to', 'molecular', 'diagnostics', 'in', 'the', 'COVID', '19', 'pandemic', 'response', 'Yet', 'the', 'scarcity', 'of', 'knowledge', 'on', 'the', 'dynamics', 'of', 'the', 'immune', 'response', 'to', 'infection', 'has', 'led', 'to', 'hesitation', 'on', 'recommending', 'the', 'use', 'of', 'rapid', 'immunodiagnostic', 'tests', 'even', 'though', 'rapid', 'serology', 'tests', 'are', 'commercially', 'available', 'and', 'scalable', 'On', 'the', 'basis', 'of', 'our', 'knowledge', 'and', 'understanding', 'of', 'viral', 'infectivity', 'and', 'host', 'response', 'we', 'urge', 'countries', 'without', 'the', 'capacity', 'to', 'do', 'molecular', 'testing', 'at', 'scale', 'to', 'research', 'the', 'use', 'of', 'serology', 'tests', 'to', 'triage', 'symptomatic', 'patients', 'in', 'community', 'settings', 'to', 'test', 'contacts', 'of', 'confirmed', 'cases', 'and', 'in', 'situational', 'analysis', 'and', 'surveillance', 'The', 'WHO', 'R', 'D', 'Blue', 'Print', 'expert', 'group', 'identified', 'eight', 'priorities', 'for', 'research', 'and', 'development', 'of', 'which', 'the', 'highest', 'is', 'to', 'mobilise', 'research', 'on', 'rapid', 'point', 'of', 'care', 'diagnostics', 'for', 'use', 'at', 'the', 'community', 'level', 'This', 'research', 'should', 'inform', 'control', 'programmes', 'of', 'the', 'required', 'performance', 'and', 'utility', 'of', 'rapid', 'serology', 'tests', 'which', 'when', 'applied', 'specifically', 'for', 'appropriate', 'public', 'health', 'measures', 'to', 'then', 'be', 'put', 'in', 'place', 'can', 'make', 'a', 'huge', 'difference', '']"
190512,Causes of endogenous uveitis in cats presented to referral clinics in North Carolina,2015-11-12,Vet Ophthalmol,https://www.ncbi.nlm.nih.gov/pubmed/26559384/; https://doi.org/10.1111/vop.12324,"OBJECTIVE: To investigate the causes of endogenous uveitis in cats presenting to referral ophthalmology clinics in North Carolina. PROCEDURE: Medical records of cats diagnosed with endogenous uveitis at North Carolina State University's College of Veterinary Medicine (NCSU‐CVM) or Animal Eye Care Associates of Cary, NC between 2003 and 2015 were reviewed. Inclusion criteria were cats that had complete diagnostic workups, including clinical, clinicopathological, serological, and histopathological data, as well as imaging modalities. Serology was consistently completed for feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), feline coronavirus (FCoV), Toxoplasma gondii, and Bartonella spp. RESULTS: One hundred and twenty cats met the inclusion criteria. Seroprevalence of FeLV (2.7%), FIV (7.3%), FCoV (34.7%), T. gondii (23.7%), and Bartonella spp. (43.2%) was observed, with a combined seroprevalence of 59.2%. Nineteen cats (15.8%) were diagnosed with feline infectious peritonitis (FIP) based on clinical, hematological, serological, histopathological, and necropsy findings. The average age of all cases was 7.62 years, while the average age of cats diagnosed with FIP was 1.82 years. Neoplasia was diagnosed in six cats (5.0%). No underlying etiology was found in 49 cats (40.8%). CONCLUSIONS: Both idiopathic and neoplastic causes of uveitis were less prevalent than previously reported in studies, while seropositivity was higher than previously reported for the study area. This may be due to improved diagnostic capabilities or that cats with infectious disease were more likely to be referred. Because of the high prevalence of FIP, young cats with uveitis should be evaluated for hyperglobulinemia and FCoV serology should be performed as minimal diagnostics.",10.1111/vop.12324,zdpbrprg,"['OBJECTIVE', 'To', 'investigate', 'the', 'causes', 'of', 'endogenous', 'uveitis', 'in', 'cats', 'presenting', 'to', 'referral', 'ophthalmology', 'clinics', 'in', 'North', 'Carolina', 'PROCEDURE', 'Medical', 'records', 'of', 'cats', 'diagnosed', 'with', 'endogenous', 'uveitis', 'at', 'North', 'Carolina', 'State', 'University', 's', 'College', 'of', 'Veterinary', 'Medicine', 'NCSU', 'CVM', 'or', 'Animal', 'Eye', 'Care', 'Associates', 'of', 'Cary', 'NC', 'between', '2003', 'and', '2015', 'were', 'reviewed', 'Inclusion', 'criteria', 'were', 'cats', 'that', 'had', 'complete', 'diagnostic', 'workups', 'including', 'clinical', 'clinicopathological', 'serological', 'and', 'histopathological', 'data', 'as', 'well', 'as', 'imaging', 'modalities', 'Serology', 'was', 'consistently', 'completed', 'for', 'feline', 'leukemia', 'virus', 'FeLV', 'feline', 'immunodeficiency', 'virus', 'FIV', 'feline', 'coronavirus', 'FCoV', 'Toxoplasma', 'gondii', 'and', 'Bartonella', 'spp', 'RESULTS', 'One', 'hundred', 'and', 'twenty', 'cats', 'met', 'the', 'inclusion', 'criteria', 'Seroprevalence', 'of', 'FeLV', '2', '7', 'FIV', '7', '3', 'FCoV', '34', '7', 'T', 'gondii', '23', '7', 'and', 'Bartonella', 'spp', '43', '2', 'was', 'observed', 'with', 'a', 'combined', 'seroprevalence', 'of', '59', '2', 'Nineteen', 'cats', '15', '8', 'were', 'diagnosed', 'with', 'feline', 'infectious', 'peritonitis', 'FIP', 'based', 'on', 'clinical', 'hematological', 'serological', 'histopathological', 'and', 'necropsy', 'findings', 'The', 'average', 'age', 'of', 'all', 'cases', 'was', '7', '62', 'years', 'while', 'the', 'average', 'age', 'of', 'cats', 'diagnosed', 'with', 'FIP', 'was', '1', '82', 'years', 'Neoplasia', 'was', 'diagnosed', 'in', 'six', 'cats', '5', '0', 'No', 'underlying', 'etiology', 'was', 'found', 'in', '49', 'cats', '40', '8', 'CONCLUSIONS', 'Both', 'idiopathic', 'and', 'neoplastic', 'causes', 'of', 'uveitis', 'were', 'less', 'prevalent', 'than', 'previously', 'reported', 'in', 'studies', 'while', 'seropositivity', 'was', 'higher', 'than', 'previously', 'reported', 'for', 'the', 'study', 'area', 'This', 'may', 'be', 'due', 'to', 'improved', 'diagnostic', 'capabilities', 'or', 'that', 'cats', 'with', 'infectious', 'disease', 'were', 'more', 'likely', 'to', 'be', 'referred', 'Because', 'of', 'the', 'high', 'prevalence', 'of', 'FIP', 'young', 'cats', 'with', 'uveitis', 'should', 'be', 'evaluated', 'for', 'hyperglobulinemia', 'and', 'FCoV', 'serology', 'should', 'be', 'performed', 'as', 'minimal', 'diagnostics', '']"
199355,COVID‐19 Clinical Diagnostics and Testing Technology,2020-07-08,Pharmacotherapy,https://doi.org/10.1002/phar.2439; https://www.ncbi.nlm.nih.gov/pubmed/32643218/,"Given the global nature of the COVID‐19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS‐CoV‐2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID‐19 diagnostics on the horizon. Antibody response against SARS‐CoV‐2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",10.1002/phar.2439,5mf1r24m,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
